disopyramide has been researched along with Arrhythmia in 342 studies
Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Furthermore, the Cardiac Arrhythmia Pilot Study compared moricizine in postinfarction patients with encainide and flecainide." | 10.16 | Comparisons of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias. ( Anderson, JL, 1990) |
| "In the context of an open multicentre study, 593 patients participated in the evaluation of sustained release disopyramide (*) in the treatment of cardiac arrhythmias." | 9.07 | [Efficacy and tolerability of sustained-release disopyramide in the treatment of cardiac arrhythmia. Results of a study with 593 patients]. ( Kacet, S; Lacroix, D; Lekieffre, J; Vaur, L, 1993) |
| "The authors report the results of an open randomized study to compare the efficacy of oral slow-release and immediate-release disopyramide, in the treatment of patients with chronic stable ventricular arrhythmias, evaluated with two Holter recordings." | 9.07 | [Delayed-action disopyramide in the treatment of hyperkinetic ventricular arrhythmia. A randomized clinical comparative study vs immediate-action disopyramide]. ( Cazzani, E; Muzio, L; Romanò, M; Spinelli, A, 1991) |
| "In a randomized open study with intravenous lignocaine and disopyramide in patients with suspected acute myocardial infarction and ventricular premature contractions the occurrence of cardiac events, adverse reactions, withdrawals and arrhythmias were compared." | 9.06 | Tolerability and antiarrhythmic efficacy of disopyramide compared to lignocaine in selected patients with suspected acute myocardial infarction. ( Abrahamsen, AM; Gundersen, T; Rønnevik, PK, 1987) |
| "The efficacy of disopyramide compared to placebo for exercise induced ventricular arrhythmias was tested in a double-blind randomized controlled clinical trial with cross-over design in 14 patients with coronary heart disease." | 9.06 | Efficacy of and adverse effects of disopyramide. Comparison of capsules, controlled release tablets and placebo in patients with chronic ventricular arrhythmias. ( Ekelund, LG; Nilsson, E; Walldius, G, 1986) |
| "473 patients with suspected acute myocardial infarction were entered into a randomised, double-blind, placebo-controlled comparison of disopyramide phosphate, 150 mg three times a day, and oxprenolol, 40 mg three times a day." | 9.05 | Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction. ( Banks, DC; Hampton, JR; Mitchell, JR; Roland, JM; Rowley, JM; Wilcox, RG, 1980) |
| "Patients with acute myocardial infarction admitted to a coronary care unit were given either intravenous and oral disopyramide or matching placebo on admission and throughout their hospital stay." | 9.05 | Intravenous and oral disopyramide after myocardial infarction. ( Barnes, PC; Haybyrne, T; Nicholls, DP, 1980) |
| "1 To evaluate oral disopyramide phosphate in the prophylaxis of dysrhythmias occurring in acute myocardial infarction (MI) patients (presenting within 12 h of symptoms, age 21-70 years), a placebo-controlled, randomized double-blind, in hospital trial was conducted." | 9.05 | A placebo-controlled study to determine the efficacy of oral disopyramide phosphate for the prophylaxis of ventricular dysrhythmias after acute myocardial infarction. ( Cairns, JA; Gent, M; Gupta, RN; Johnson, AL; Johnston, M; Kumana, CR; Rambihar, VS; Tanser, PH; Wildeman, RA, 1982) |
| "Forty patients with serious lidocaine-responsive ventricular arrhythmias were randomly assigned to treatment with either oral disopyramide (100 mg 4 times daily) or mexiletine (200 mg 4 times daily) for 3 weeks." | 9.05 | Disopyramide and mexiletine: which is the agent of choice in the long term-oral treatment of lidocaine-responsive arrhythmias? Efficacy comparison in a randomized trial. ( Condorelli, M; De Luca, N; Rengo, F; Ricciardelli, B; Sacca', L; Trimarco, B; Volpe, M, 1980) |
| "Low-dose (7 mg/kg per day) disopyramide administration to arrhythmic chagasic patients decreased the frequency of ventricular extrasystoles in 4 of 17 patients (24%) and suppressed most complex ventricular arrhythmias in 12 of 15 patients (80%)." | 9.05 | Effect of low oral doses of disopyramide and amiodarone on ventricular and atrial arrhythmias of chagasic patients with advanced myocardial damage. ( Carrasco, HA; Fuenmayor, A; Landaeta, A; López, F; Molina, C; Reynosa, J; Vicuña, AV; Vicuña, N, 1985) |
| "Oral disopyramide given prophylactically following myocardial infarction has been compared with placebo in a double-blind trial using continuous-tape monoriting of the electocardiogram." | 9.04 | Oral disopyramide in prophylaxis of arrhythmias following myocardial infarction. ( Besterman, EM; Jennings, G; Jones, MS; Kidner, PH; Model, DG; Turner, PP, 1976) |
| "Patients with acute myocardial infarction admitted to open wards of three hospitals were given either oral disopyramide (100 mg four times daily) or matching placebo, prophylactically, for seven days." | 9.04 | Oral disopyramide for the prevention of arrhythmias in patients with acute myocardial infarction admitted to open wards. ( Besterman, EM; Carmichael, DJ; Gillham, AD; Griffiths, JW; Kidner, PH; Summers, GD; Zainal, N, 1977) |
| "The incidence of ventricular arrhythmias after myocardial infarction was compared in a double blind study of disopyramide (33 patients), aprindine (34 patients) and placebo (31 patients)." | 9.04 | Effects of disopyramide and aprindine on arrhythmias after acute myocardial infarction. ( Chaudron, JM; Pouleur, H; Reyns, P, 1977) |
| "Twenty-six patients with clinically significant ventricular arrhythmias were randomly assigned to treatment with either intravenous disopyramide or lidocaine; crossover to the other agent was permitted in nine cases of primary drug failure." | 9.04 | Suppression of ventricular arrhythmias with intravenous disopyramide and lidocaine: efficacy comparison in a randomized trial. ( Fozzard, HA; Rawling, DA; Sbarbaro, JA, 1979) |
| "The response of arrhythmias to oral disopyramide in relation to its serum levels has been documented." | 9.04 | Disopyramide: serum level and arrhythmia conversion. ( Niarchos, AP, 1976) |
| "The relationship between the duration of arrhythmia and the subsequent long-term efficacy of disopyramide in preventing atrial fibrillation was investigated in patients with symptomatic paroxysmal and persistent atrial fibrillation." | 7.72 | [Relationship between duration of arrhythmia and subsequent preventive effect of disopyramide after cardioversion in patients with symptomatic paroxysmal and persistent atrial fibrillation]. ( Abe, N; Horiuchi, D; Kameda, K; Komatsu, T; Nakamura, S; Oikawa, K; Okumura, K; Owada, S; Suzuki, O; Tomita, H; Yomogida, K, 2003) |
| "Antiarrhythmic effects of bisaramil were examined by using new in vivo triggered arrhythmia models, and they were compared with those of other antiarrhythmic drugs." | 7.69 | Antiarrhythmic effects of bisaramil on triggered arrhythmias produced by intracoronary injection of digitalis and adrenaline in the dog. ( Haruno, A; Hashimoto, K, 1995) |
| "Disopyramide is an effective class I antiarrhythmic drug and widely used for the treatment of arrhythmias, but it has anticholinergic side effects." | 7.69 | Antiarrhythmic effects of optical isomers of disopyramide on canine ventricular arrhythmias. ( Eto, K; Hashimoto, K; Nakamura, M; Xue, Y, 1996) |
| "We investigated the effects of (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate (Ro 22-9194), a novel class I antiarrhythmic agent, on myocardial ischemia- and reperfusion-induced arrhythmias in dogs." | 7.69 | Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory act ( Kanazawa, T; Kinukawa, M; Maruyama, K; Miyagi, M; Miyata, H; Murakami, M; Ujiie, A, 1996) |
| "A study of the efficacy of intravenous disopyramide in the conversion of supraventricular tachyarrhythmias to sinus rhythm was undertaken in a group of 23 patients with a variety of cardiological diagnoses." | 7.67 | The use of intravenous disopyramide for the conversion of supraventricular tachyarrhythmias. ( Ikram, H; Stewart, DE, 1984) |
| "Controlled-release (CR) disopyramide phosphate has been available for the past four years for the management of patients with ventricular arrhythmias." | 7.67 | Long-term use of controlled-release disopyramide in patients with severe ventricular arrhythmias. ( Paulk, EA, 1987) |
| "The pharmacokinetics of the controlled-release preparation of disopyramide phosphate (Norpace CR, Searle Laboratories, Chicago, IL) were studied in ten patients with cardiac arrhythmias." | 7.67 | Clinical pharmacokinetics of controlled-release disopyramide in patients with cardiac arrhythmias. ( Capparelli, EV; Chow, MS; DiPersio, DM; Kluger, J; Zhao, H, 1988) |
| "We examined effects of 711389-S, a new antiarrhythmic agent, on ouabain-induced arrhythmias in dogs and guinea-pigs, aconitine-induced arrhythmias in dogs and mice, adrenaline-induced arrhythmias in dogs under an anesthetized condition, and arrhythmias induced by coronary artery ligation and occlusion by a glass bead in dogs under conscious and un-restrained conditions." | 7.67 | Actions of a newly synthesized compound (711389-S) on various types of experimentally induced arrhythmias in mammalian species in situ. ( Haruna, M; Hotokebuchi, N; Kadowaki, Y; Kimoto, S; Nakao, T; Nishi, K; Ohta, T; Ueda, M, 1988) |
| "The efficacy of intravenous disopyramide was studied during 200 episodes of supraventricular and ventricular arrhythmias in 160 patients, mainly presenting with acute myocardial infarction or cardiac failure." | 7.66 | Efficacy of intravenous disopyramide in acute cardiac arrhythmias. ( De Backer, M; Kahn, RJ; Stoupel, E, 1981) |
| "Antiarrhythmic actions of lorcainide were compared with those of disopyramide on different types of arrhythmias in animal models." | 7.66 | [Effects of lorcainide, a new antiarrhythmic agent, on experimental cardiac arrhythmias]. ( Fukuda, H; Goto, M; Kondo, M; Sekino, Y; Uchigasaki, T, 1983) |
| "A patient presenting with atypical ventricular tachycardia due to oral disopyramide given in normal doses over a period of four months is described." | 7.66 | Disopyramide induced atypical ventricular tachycardia. ( Chia, BL, 1980) |
| "The effects of intravenous doses of Org 6001 and disopyramide (10 mg/kg) known to confer protection against early postligation-induced arrhythmias in the anaesthetized rat when given prophylactically, were assessed following postligation administration." | 7.66 | The effects of postligation administration of ORG 6001 and disopyramide on early ischaemia-induced arrhythmias in the anaesthetized rat. ( Marshall, RJ; Muir, AW; Winslow, E, 1982) |
| "Disopyramide phosphate (DF) was administered intravenously to 50 patients during 55 episodes of arrhythmias." | 7.66 | [Intravenously disopyramide phosphate administration for treatment of arrhythmias]. ( Aquaro, G; Belli, R; Idone, P; Pavia, M; Possavino, G; Ravera, A; Rey, L, 1982) |
| "The parmacokinetics of disopyramide (DP) in 10 patients with imminent to moderate cardiac failure has been studied and compared with the results in normal volunteers." | 7.66 | Pharmacokinetics of disopyramide in patients with imminent to moderate cardiac failure. ( Amlie, JP; Bredesen, JE; Landmark, K; Simonsen, S; Thaulow, E, 1981) |
| "The electrophysiologic actions of disopyramide phosphate on reentrant ventricular tachycardia induced by premature ventricular stimuli were evaluated in conscious dogs 2 to 4 days after myocardial infarction." | 7.66 | Electrophysiologic effects of disopyramide phosphate on reentrant ventricular arrhythmia in conscious dogs after myocardial infarction. ( Gibson, JK; Lucchesi, BR; Patterson, E, 1980) |
| "Three cases are described with documented ventricular fibrillation shortly after the patients received disopyramide in moderate dosage." | 7.66 | Disopyramide-induced ventricular fibrillation. ( Gracey, JG; Knoch, HR; Martin, CE; Nicholson, WJ, 1979) |
| "The effect of administration of disopyramide on the ventricular response to atrial fibrillation was studied in six patients with the Wolff-Parkinson-White syndrome." | 7.66 | Disopyramide in patients with the Wolff-Parkinson-White syndrome and atrial fibrillation. ( Bennett, DH, 1978) |
| "Seventeen patients with recurrent symptomatic arrhythmias were treated with oral disopyramide (DP)." | 7.66 | Clinical and electrophysiological observations with disopyramide in drug-resistant and recurrent symptomatic arrhythmias. ( Millar, RN; Myers, JB; Obel, IW, 1978) |
| "Disopyramide, a new anti-arrhythmic drug, has been assessed in twenty-one episodes of cardiac arrhythmia secondary to acute ischaemic heart disease which failed to respond to more conventional suppressive therapy with lignocaine and other standard drugs." | 7.65 | The use of disopyramide in resistant cardiac arrhythmias due to acute ischaemic heart disease. ( Sandler, G, 1977) |
| "A myocardial infarction model in which infarction is the result of an occluding thrombus was used to evaluate the effectiveness of disopyramide phosphate (DP) in abolishing postinfarction ventricular arrhythmis." | 7.65 | Effects of disopyramide phosphate on ventricular arrhythmias in experimental myocardial infarction. ( Kus, T; Sasyniuk, BI, 1976) |
| "With disopyramide this increase was not significant." | 6.66 | Comparative study of encainide and disopyramide in chronic ventricular arrhythmias: a double-blind placebo-controlled crossover study. ( Caron, JF; Dupuis, BA; Kacet, S; Kher, AR; Lekieffre, JP; Libersa, CC; Poirier, JM; Wanszelbaum, H, 1985) |
| "Flecainide was as effective as the combination of digoxin and disopyramide and it acted significantly faster and was associated with fewer relapses." | 6.66 | Flecainide compared with a combination of digoxin and disopyramide for acute atrial arrhythmias after cardiopulmonary bypass. ( Campbell, TJ; Gavaghan, TP; Kelly, RP; Koegh, AM; Morgan, JJ; Thorburn, C, 1988) |
| "Propafenone also showed a lower incidence of side effects." | 6.66 | Comparison of propafenone and disopyramide for treatment of chronic ventricular arrhythmias: placebo-controlled, double-blind, randomized crossover study. ( Ambrosioni, E; Bertaccini, P; Bracchetti, D; Cantelli, I; Naccarella, F; Palmieri, M, 1985) |
| " Although both drugs significantly reduced VPDs relative to placebo, ethmozine was a superior antiarrhythmic drug in ach9eving near-total abolition of VPDs (30% of patients), which was never observed during disopyramide dosing (p less than ." | 6.65 | Comparative effect of disopyramide and ethmozine in suppressing complex ventricular arrhythmias by use of a double-blind, placebo-controlled, longitudinal crossover design. ( English, L; Francis, MJ; Kopelen, H; Mann, DE; Norton, HJ; Pratt, CM; Quinones, MA; Roberts, R; Taylor, AA; Young, JB, 1984) |
| " The high incidence of side-effects was probably due to the high dosage used." | 6.65 | Evaluation of the antiarrhythmic efficacy of mexiletine in patients with chronic ventricular arrhythmias. ( Van Durme, JP, 1980) |
| "Out of the 28 severe arrhythmias studied, it was the ventricular extrasystoles which benefited most from treatment (79% completely successful, while there was a lesser degree of success in treating the ventricular tachycardias (35% completely successful, 30% partially successful)." | 6.64 | [Action of injected disopyramide on ventricular arrhythmias and atrioventricular conduction]. ( Bellanger, P; Desoutter, P; Motté, G; Vogel, M; Welti, JJ, 1976) |
| "Disopyramide is a widely used class IA antiarrhythmic drug with a pharmacological profile of action similar to that of quinidine and procainamide." | 6.37 | Disopyramide. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiac arrhythmias. ( Brogden, RN; Todd, PA, 1987) |
| "Disopyramide is a new antiarrhythmic drug with a pharmacological profile of action similar to that of quinidine and procainamide." | 6.36 | Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias. ( Avery, GS; Brogden, RN; Heel, RC; Speight, TM, 1978) |
| " Furthermore, the Cardiac Arrhythmia Pilot Study compared moricizine in postinfarction patients with encainide and flecainide." | 6.16 | Comparisons of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias. ( Anderson, JL, 1990) |
| "Since its approval by the FDA six years ago, oral disopyramide has earned a recognized role in the treatment of ventricular arrhythmias." | 6.15 | Disopyramide: six years' experience. ( Wallace, AG; Wilson, RR, 1983) |
| " For this purpose, we plotted a dose-response curve for adrenaline by calculating the arrhythmic ratio, which is the number of ventricular ectopic beats induced by adrenaline divided by the total heart rate, and observed the changes in the arrhythmic ratio-adrenaline dose relation before and after administration of class I drugs." | 5.31 | QT-prolonging class I drug, disopyramide, does not aggravate but suppresses adrenaline-induced arrhythmias. Comparison with cibenzoline and pilsicainide. ( Aye, NN; Hashimoto, K; Miyamoto, S; Teramatsu, T; Zhu, B, 2000) |
| "Disopyramide was metabolized by the cytochrome enzyme CYP3A4 and clarithromycin competitively inhibits this enzyme, probably resulting in an increase in plasma concentration of disopyramide." | 5.30 | Torsades de pointes ventricular tachycardia induced by clarithromycin and disopyramide in the presence of hypokalemia. ( Hashimoto, T; Hayashi, Y; Ikeda, U; Mitsuhashi, T; Shimada, K; Watanabe, T, 1999) |
| "Moricizine (moracizine) is a new class I antiarrythmic drug which is undergoing a large scale clinical trial at present." | 5.28 | The effect of pretreatment with moricizine on early arrhythmia resulting from myocardial ischemia in rats. ( Hashimoto, K; He, ZS; Komori, S; Tamura, K, 1992) |
| " A sustained-release preparation of DP may be required for pediatric patients to minimize a large fluctuation of plasma drug levels during the dosing intervals." | 5.28 | Steady-state pharmacokinetics and bioavailability of total and unbound disopyramide in children with cardiac arrhythmias. ( Chiba, K; Echizen, H; Ishizaki, T; Ishizawa, A; Koike, K; Nakamoto, M, 1992) |
| "In the treatment of extrasystole, the arrhythmia was eliminated or reduced by 75% in 15 of 23 patients." | 5.26 | [Oral longterm therapy with disopyramide phosphate in patients with atrial and ventricular arrhythmias (author's transl)]. ( Grewe, N; Stauch, M, 1977) |
| "In the context of an open multicentre study, 593 patients participated in the evaluation of sustained release disopyramide (*) in the treatment of cardiac arrhythmias." | 5.07 | [Efficacy and tolerability of sustained-release disopyramide in the treatment of cardiac arrhythmia. Results of a study with 593 patients]. ( Kacet, S; Lacroix, D; Lekieffre, J; Vaur, L, 1993) |
| "The authors report the results of an open randomized study to compare the efficacy of oral slow-release and immediate-release disopyramide, in the treatment of patients with chronic stable ventricular arrhythmias, evaluated with two Holter recordings." | 5.07 | [Delayed-action disopyramide in the treatment of hyperkinetic ventricular arrhythmia. A randomized clinical comparative study vs immediate-action disopyramide]. ( Cazzani, E; Muzio, L; Romanò, M; Spinelli, A, 1991) |
| "In a randomized open study with intravenous lignocaine and disopyramide in patients with suspected acute myocardial infarction and ventricular premature contractions the occurrence of cardiac events, adverse reactions, withdrawals and arrhythmias were compared." | 5.06 | Tolerability and antiarrhythmic efficacy of disopyramide compared to lignocaine in selected patients with suspected acute myocardial infarction. ( Abrahamsen, AM; Gundersen, T; Rønnevik, PK, 1987) |
| "The efficacy of disopyramide compared to placebo for exercise induced ventricular arrhythmias was tested in a double-blind randomized controlled clinical trial with cross-over design in 14 patients with coronary heart disease." | 5.06 | Efficacy of and adverse effects of disopyramide. Comparison of capsules, controlled release tablets and placebo in patients with chronic ventricular arrhythmias. ( Ekelund, LG; Nilsson, E; Walldius, G, 1986) |
| "473 patients with suspected acute myocardial infarction were entered into a randomised, double-blind, placebo-controlled comparison of disopyramide phosphate, 150 mg three times a day, and oxprenolol, 40 mg three times a day." | 5.05 | Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction. ( Banks, DC; Hampton, JR; Mitchell, JR; Roland, JM; Rowley, JM; Wilcox, RG, 1980) |
| "Patients with acute myocardial infarction admitted to a coronary care unit were given either intravenous and oral disopyramide or matching placebo on admission and throughout their hospital stay." | 5.05 | Intravenous and oral disopyramide after myocardial infarction. ( Barnes, PC; Haybyrne, T; Nicholls, DP, 1980) |
| "Oral long-term treatment with various antiarrhythmic drugs (aprindine, mexiletine, disopyramide, amiodarone) was assessed in 82 patients with recurrent tachycardias demonstrated in the ECG using programmed ventricular stimulation." | 5.05 | [Long-term drug therapy in ventricular cardiac arrhythmias. Is an improvement of the prognosis possible?]. ( Lüderitz, B; Manz, M; Steinbeck, G, 1983) |
| "A study was carried out in 33 patients with myocardial infarction and complicating arrhythmias to compare plasma levels of disopyramide attained after administration of conventional capsules or sustained-release tablets." | 5.05 | Plasma levels of disopyramide after administration of conventional capsules and sustained-release tablets. ( Hertzberger, DP; Nauta, IL; van de Calseyde, J, 1983) |
| "1 To evaluate oral disopyramide phosphate in the prophylaxis of dysrhythmias occurring in acute myocardial infarction (MI) patients (presenting within 12 h of symptoms, age 21-70 years), a placebo-controlled, randomized double-blind, in hospital trial was conducted." | 5.05 | A placebo-controlled study to determine the efficacy of oral disopyramide phosphate for the prophylaxis of ventricular dysrhythmias after acute myocardial infarction. ( Cairns, JA; Gent, M; Gupta, RN; Johnson, AL; Johnston, M; Kumana, CR; Rambihar, VS; Tanser, PH; Wildeman, RA, 1982) |
| "Forty patients with serious lidocaine-responsive ventricular arrhythmias were randomly assigned to treatment with either oral disopyramide (100 mg 4 times daily) or mexiletine (200 mg 4 times daily) for 3 weeks." | 5.05 | Disopyramide and mexiletine: which is the agent of choice in the long term-oral treatment of lidocaine-responsive arrhythmias? Efficacy comparison in a randomized trial. ( Condorelli, M; De Luca, N; Rengo, F; Ricciardelli, B; Sacca', L; Trimarco, B; Volpe, M, 1980) |
| "Low-dose (7 mg/kg per day) disopyramide administration to arrhythmic chagasic patients decreased the frequency of ventricular extrasystoles in 4 of 17 patients (24%) and suppressed most complex ventricular arrhythmias in 12 of 15 patients (80%)." | 5.05 | Effect of low oral doses of disopyramide and amiodarone on ventricular and atrial arrhythmias of chagasic patients with advanced myocardial damage. ( Carrasco, HA; Fuenmayor, A; Landaeta, A; López, F; Molina, C; Reynosa, J; Vicuña, AV; Vicuña, N, 1985) |
| "Oral disopyramide given prophylactically following myocardial infarction has been compared with placebo in a double-blind trial using continuous-tape monoriting of the electocardiogram." | 5.04 | Oral disopyramide in prophylaxis of arrhythmias following myocardial infarction. ( Besterman, EM; Jennings, G; Jones, MS; Kidner, PH; Model, DG; Turner, PP, 1976) |
| "Patients with acute myocardial infarction admitted to open wards of three hospitals were given either oral disopyramide (100 mg four times daily) or matching placebo, prophylactically, for seven days." | 5.04 | Oral disopyramide for the prevention of arrhythmias in patients with acute myocardial infarction admitted to open wards. ( Besterman, EM; Carmichael, DJ; Gillham, AD; Griffiths, JW; Kidner, PH; Summers, GD; Zainal, N, 1977) |
| "Ten patients with various heart diseases and ventricular arrhythmia received a single oral dose of disopyramide (DE) 200 mg." | 5.04 | Antiarrhythmic and electrocardiographic effects of single oral doses of disopyramide. ( Hulting, J; Jansson, B, 1977) |
| "The incidence of ventricular arrhythmias after myocardial infarction was compared in a double blind study of disopyramide (33 patients), aprindine (34 patients) and placebo (31 patients)." | 5.04 | Effects of disopyramide and aprindine on arrhythmias after acute myocardial infarction. ( Chaudron, JM; Pouleur, H; Reyns, P, 1977) |
| "Twenty-six patients with clinically significant ventricular arrhythmias were randomly assigned to treatment with either intravenous disopyramide or lidocaine; crossover to the other agent was permitted in nine cases of primary drug failure." | 5.04 | Suppression of ventricular arrhythmias with intravenous disopyramide and lidocaine: efficacy comparison in a randomized trial. ( Fozzard, HA; Rawling, DA; Sbarbaro, JA, 1979) |
| "The response of arrhythmias to oral disopyramide in relation to its serum levels has been documented." | 5.04 | Disopyramide: serum level and arrhythmia conversion. ( Niarchos, AP, 1976) |
| "Since disopyramide was introduced 5 years ago, the therapeutic spectrum of this drug in treating patients with ventricular and atrial arrhythmias has been found to be similar to that of the other type I antiarrhythmic drugs, quinidine and procainamide." | 4.76 | Disopyramide. ( Desai, J; Morady, F; Scheinman, MM, 1982) |
| " The purpose of this study was to assess the efficacy of the AADs disopyramide, quinidine, and propafenone on human atrial arrhythmias mediated by Pitx2-induced remodelling, from a single cell to the tissue level, using drug binding models with multi-channel pharmacology." | 4.02 | In Silico Assessment of Class I Antiarrhythmic Drug Effects on ( Bai, J; Gao, M; Lo, A; Lu, Y; Zhang, H; Zhao, J; Zhu, Y, 2021) |
| "Disopyramide, an antiarrhythmia drug, has been reported to cause hypoglycaemia." | 3.75 | Mechanism of disopyramide-induced hypoglycaemia in a patient with Type 2 diabetes. ( Mori, M; Negishi, M; Proks, P; Shimomura, K; Shimomura, Y, 2009) |
| " Therapy with beta-adrenoblockers, amiodarone and sotalol in patients with ventricular arrhythmias was associated with improvement of parameters of SA ECG, lowering of sympathetic and augmentation of parasympathetic activity without sings of arrhrythmogenic and negative inotropic effects." | 3.72 | [Anti-arrhythmic therapy: diagnostic possibilities of signal-averaged electrocardiography and heart rate variability]. ( Morozova, OI; Pozdniakova, NV; Shevyrev, VA; Tatarchenko, IP, 2003) |
| "The relationship between the duration of arrhythmia and the subsequent long-term efficacy of disopyramide in preventing atrial fibrillation was investigated in patients with symptomatic paroxysmal and persistent atrial fibrillation." | 3.72 | [Relationship between duration of arrhythmia and subsequent preventive effect of disopyramide after cardioversion in patients with symptomatic paroxysmal and persistent atrial fibrillation]. ( Abe, N; Horiuchi, D; Kameda, K; Komatsu, T; Nakamura, S; Oikawa, K; Okumura, K; Owada, S; Suzuki, O; Tomita, H; Yomogida, K, 2003) |
| "Cases of severe cardiac arrhythmia and major hypoglycaemia have occurred in patients receiving disopyramide simultaneously with some macrolide antibiotics, especially erythromycin and clarithromycin." | 3.71 | Disopyramide: interactions with marcolide antibiotics. ( , 2001) |
| "Antiarrhythmic effects and cardiovascular effects of pilsicainide hydrochloride were compared with those of disopyramide in a canine model of coronary ligation-induced ventricular arrhythmias and anesthetized dogs." | 3.70 | [Antiarrhythmic effects of pilsicainide hydrochloride and effects on cardiac function and ECG in dogs: comparison with disopyramide]. ( Hayashi, Y; Hidaka, T; Inomata, N; Inoue, T; Komoriya, K, 2000) |
| "Antiarrhythmic effects of bisaramil were examined by using new in vivo triggered arrhythmia models, and they were compared with those of other antiarrhythmic drugs." | 3.69 | Antiarrhythmic effects of bisaramil on triggered arrhythmias produced by intracoronary injection of digitalis and adrenaline in the dog. ( Haruno, A; Hashimoto, K, 1995) |
| "Disopyramide is an effective class I antiarrhythmic drug and widely used for the treatment of arrhythmias, but it has anticholinergic side effects." | 3.69 | Antiarrhythmic effects of optical isomers of disopyramide on canine ventricular arrhythmias. ( Eto, K; Hashimoto, K; Nakamura, M; Xue, Y, 1996) |
| "We investigated the effects of (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate (Ro 22-9194), a novel class I antiarrhythmic agent, on myocardial ischemia- and reperfusion-induced arrhythmias in dogs." | 3.69 | Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory act ( Kanazawa, T; Kinukawa, M; Maruyama, K; Miyagi, M; Miyata, H; Murakami, M; Ujiie, A, 1996) |
| "Disopyramide as an antiarrhythmic can be prescribed to patients with atrial fibrillation and, owing to its negative inotropic effect, to patients with hypertrophic obstructive cardiomyopathy." | 3.69 | Heart conduction disturbances and cardiovascular collapse after disopyramide and low-dose metoprolol in a patient with hypertrophic obstructive cardiomyopathy. ( Horvat, M; Pernat, A; Pohar, B, 1997) |
| "A series of 12-aminotetrahydroisoquinocarbazoles and related compounds were synthesized using an intramolecular Diels-Alder reaction and screened for antiarrhythmic activity in chloroform-induced ventricular arrhythmias in mice." | 3.68 | Synthesis and biological action of the aminotetrahydroisoquinocarbazoles and related compounds: a new class of compounds with antiarrhythmic activity. ( Hashimoto, T; Koike, H; Mizuno, H; Morisawa, Y; Saito, F; Shimoji, Y; Tomita, K; Yorikane, R, 1992) |
| " So we continued synthesis and evaluation of a series of 5-substituted 5,11-dihydro[1]benzoxepino[3,4-b]pyridines for antiarrhythmic activity in chloroform-induced ventricular arrhythmias in mice and in ouabain-induced ventricular arrhythmias in dogs." | 3.68 | Synthesis and antiarrhythmic activity of 5,11-dihydro[1]benzoxepino[3,4-b]pyridines. ( Harakawa, H; Ishii, A; Kubo, K; Kumazawa, T; Nito, M; Obase, H; Oiji, Y; Tomioka, S; Yamada, Y, 1990) |
| "The effects of cisapride on the gastrointestinal contractile activity and pharmacokinetics of disopyramide were determined in beagle dogs and patients with arrhythmia." | 3.68 | Effects of cisapride on gastrointestinal motor activity and gastric emptying of disopyramide. ( Akima, M; Azumi, T; Fukuzaki, H; Inatome, T; Kuroda, T; Nakamura, H; Takanashi, H; Yogo, K; Yoshihara, Y, 1992) |
| "Palpitin, an agent of the disopyramide series, was evaluated for its antiarrhythmic potency in the treatment of ventricular and supraventricular arrhythmias and for its effects of ECG and central hemodynamic parameters in 108 patients (91 had coronary heart disease, 8 presented with postmyocardial cardiosclerosis, 5 had hypertensive disease, and 4 suffered from neurocirculatory dystonia)." | 3.68 | [Assessment of anti-arrhythmic activity of palpitin and cardio-hemodynamic effects of its administration]. ( Gorshkov, VA; Kurakina, TI; Nesvetov, VN, 1990) |
| " RS-2135 exerted more potent antiarrhythmic activity than reference compounds against ouabain-induced arrhythmias in dogs." | 3.68 | Antiarrhythmic and cardiovascular profiles of the fused indole compound (3aR,12R,12aR,12bS)-12-amino-2,3,3a,4,11,12,12a,12b-octahydro-10-hydrox yisoquino [2,1,8-lma]carbazol-5(1H)-one hydrochloride 1.5 hydrate. ( Fukami, M; Hashimoto, T; Itoh, Y; Koike, H; Kumakura, S; Miyake, S; Mizuno, H; Shiga, H; Shimoji, Y; Yorikane, R, 1991) |
| "Ventricular arrhythmia suppression trials were performed to compare the efficacies and side effects of disopyramide and mexiletine used alone and in combination, and to compare the efficacies and side effects of mexiletine and propranolol used alone and in combination, in patients with chronic ventricular premature contractions (VPCs, greater than or equal to 3000 beats/day)." | 3.68 | Combination antiarrhythmic treatment among class Ia, Ib, and II agents for ventricular arrhythmias. ( Tanabe, T, 1991) |
| "A study of the efficacy of intravenous disopyramide in the conversion of supraventricular tachyarrhythmias to sinus rhythm was undertaken in a group of 23 patients with a variety of cardiological diagnoses." | 3.67 | The use of intravenous disopyramide for the conversion of supraventricular tachyarrhythmias. ( Ikram, H; Stewart, DE, 1984) |
| "The efficacy and safety of a new dosage regimen of intravenous disopyramide in ventricular arrhythmias were evaluated in 10 patients." | 3.67 | Intravenous disopyramide: safety and efficacy of a new dosage regimen. ( Beck, B; Benes, J; Reddy, CP, 1984) |
| "In this study, the safety and efficacy of long-term therapy with disopyramide phosphate were evaluated in 40 patients with documented, recurrent, symptomatic tachyarrhythmias." | 3.67 | Long-term therapy with disopyramide phosphate: side effects and effectiveness. ( Bauernfeind, RA; Bauman, JL; Gallastegui, J; Hoff, J; Strasberg, B; Swiryn, S; Welch, WJ, 1986) |
| "Controlled-release (CR) disopyramide phosphate has been available for the past four years for the management of patients with ventricular arrhythmias." | 3.67 | Long-term use of controlled-release disopyramide in patients with severe ventricular arrhythmias. ( Paulk, EA, 1987) |
| "Though the efficacies of procainamide and disopyramide in treating arrhythmias are well established, their precise mechanisms of antiarrhythmic action remain unclear." | 3.67 | Effects of procainamide and disopyramide on long chain acyl carnitine and long chain acyl CoA concentrations in the ischemic heart. ( Kobayashi, A; Watanabe, H; Yamazaki, N, 1988) |
| "The efficacy of disopyramide (DP), mexiletine (MX), aprindine (AP) and cibenzoline (CZ) on ventricular arrhythmias was compared (single drug therapy)." | 3.67 | Therapeutic effectiveness and plasma levels of single or combination use of class I antiarrhythmic agents for ventricular arrhythmias. ( Furuya, H; Goto, Y; Tanabe, T; Yoshikawa, H, 1988) |
| "The pharmacokinetics of the controlled-release preparation of disopyramide phosphate (Norpace CR, Searle Laboratories, Chicago, IL) were studied in ten patients with cardiac arrhythmias." | 3.67 | Clinical pharmacokinetics of controlled-release disopyramide in patients with cardiac arrhythmias. ( Capparelli, EV; Chow, MS; DiPersio, DM; Kluger, J; Zhao, H, 1988) |
| " Twenty-six of these patients, who had ventricular fibrillation during single-drug therapy with quinidine, procainamide, or disopyramide, were compared with a control group of 62 patients who had been treated similarly for ventricular arrhythmias but did not have ventricular fibrillation during treatment." | 3.67 | Clinical characteristics of patients with ventricular fibrillation during antiarrhythmic drug therapy. ( Heger, JJ; Miles, WM; Minardo, JD; Prystowsky, EN; Zipes, DP, 1988) |
| "We examined effects of 711389-S, a new antiarrhythmic agent, on ouabain-induced arrhythmias in dogs and guinea-pigs, aconitine-induced arrhythmias in dogs and mice, adrenaline-induced arrhythmias in dogs under an anesthetized condition, and arrhythmias induced by coronary artery ligation and occlusion by a glass bead in dogs under conscious and un-restrained conditions." | 3.67 | Actions of a newly synthesized compound (711389-S) on various types of experimentally induced arrhythmias in mammalian species in situ. ( Haruna, M; Hotokebuchi, N; Kadowaki, Y; Kimoto, S; Nakao, T; Nishi, K; Ohta, T; Ueda, M, 1988) |
| " route proved to be more potent and longer-acting than disopyramide, propaphenone and mexiletine against supraventricular and ventricular arrhythmias induced by chloroform, aconitine, ouabain and halothane-adrenaline." | 3.67 | Antiarrhythmic effects of a novel diamine derivative, AN-132, on several animal models of cardiac arrhythmias. ( Sakai, K; Takagi, M; Yamazaki, T, 1987) |
| "The efficacy of intravenous disopyramide was studied during 200 episodes of supraventricular and ventricular arrhythmias in 160 patients, mainly presenting with acute myocardial infarction or cardiac failure." | 3.66 | Efficacy of intravenous disopyramide in acute cardiac arrhythmias. ( De Backer, M; Kahn, RJ; Stoupel, E, 1981) |
| "Antiarrhythmic actions of lorcainide were compared with those of disopyramide on different types of arrhythmias in animal models." | 3.66 | [Effects of lorcainide, a new antiarrhythmic agent, on experimental cardiac arrhythmias]. ( Fukuda, H; Goto, M; Kondo, M; Sekino, Y; Uchigasaki, T, 1983) |
| "The plasma concentration profile of disopyramide was examined in 13 patients with arrhythmias following acute myocardial infarction." | 3.66 | Sustained release disopyramide compared to plain capsules after change-over from intravenous infusion. ( Bakke, OM; Lien, E, 1983) |
| "A patient presenting with atypical ventricular tachycardia due to oral disopyramide given in normal doses over a period of four months is described." | 3.66 | Disopyramide induced atypical ventricular tachycardia. ( Chia, BL, 1980) |
| "The effects of intravenous doses of Org 6001 and disopyramide (10 mg/kg) known to confer protection against early postligation-induced arrhythmias in the anaesthetized rat when given prophylactically, were assessed following postligation administration." | 3.66 | The effects of postligation administration of ORG 6001 and disopyramide on early ischaemia-induced arrhythmias in the anaesthetized rat. ( Marshall, RJ; Muir, AW; Winslow, E, 1982) |
| "The effects of the antiarrhythmic drugs disopyramide (D), mexiletine (M), and propafenone (P) on left ventricular function after intravenous injection and after oral therapy of at least 48 hours, and of the combined oral application of D and M, were studied by M-mode echocardiography in patients with ventricular arrhythmias in whom antiarrhythmic therapy was indicated." | 3.66 | [The effect of disopyramide, mexiletine and propafenon after intravenous and oral administration on left ventricular function in the M-mode echocardiogram]. ( Böcker, K; Köhler, E; Loogen, F; Seipel, L, 1982) |
| "Disopyramide phosphate (DF) was administered intravenously to 50 patients during 55 episodes of arrhythmias." | 3.66 | [Intravenously disopyramide phosphate administration for treatment of arrhythmias]. ( Aquaro, G; Belli, R; Idone, P; Pavia, M; Possavino, G; Ravera, A; Rey, L, 1982) |
| "The parmacokinetics of disopyramide (DP) in 10 patients with imminent to moderate cardiac failure has been studied and compared with the results in normal volunteers." | 3.66 | Pharmacokinetics of disopyramide in patients with imminent to moderate cardiac failure. ( Amlie, JP; Bredesen, JE; Landmark, K; Simonsen, S; Thaulow, E, 1981) |
| " This arrhythmia was induced by quinidine or disopyramide therapy." | 3.66 | Ventricular pacing in atypical ventricular tachycardia. ( Benhorin, J; Corcos, P; Golhman, JM; Keren, A; Stern, S; Tzivoni, D, 1981) |
| "Disopyramide has been successfully used to treat a variety of supraventricular and ventricular arrhythmias." | 3.66 | Electrophysiologic effects of disopyramide in children. ( Kashani, IA; Shakibi, JG; Siassi, B, 1980) |
| "The electrophysiologic actions of disopyramide phosphate on reentrant ventricular tachycardia induced by premature ventricular stimuli were evaluated in conscious dogs 2 to 4 days after myocardial infarction." | 3.66 | Electrophysiologic effects of disopyramide phosphate on reentrant ventricular arrhythmia in conscious dogs after myocardial infarction. ( Gibson, JK; Lucchesi, BR; Patterson, E, 1980) |
| "Three cases are described with documented ventricular fibrillation shortly after the patients received disopyramide in moderate dosage." | 3.66 | Disopyramide-induced ventricular fibrillation. ( Gracey, JG; Knoch, HR; Martin, CE; Nicholson, WJ, 1979) |
| " disopyramide for a supraventricular tachycardia resulted in a more serious ventricular dysrhythmia giving hypotension and this probably contributed to the development of a myocardial infarction." | 3.66 | Adverse reaction to disopyramide. ( Dibble, JB; Webster, NR, 1979) |
| "The effect of administration of disopyramide on the ventricular response to atrial fibrillation was studied in six patients with the Wolff-Parkinson-White syndrome." | 3.66 | Disopyramide in patients with the Wolff-Parkinson-White syndrome and atrial fibrillation. ( Bennett, DH, 1978) |
| "Seventeen patients with recurrent symptomatic arrhythmias were treated with oral disopyramide (DP)." | 3.66 | Clinical and electrophysiological observations with disopyramide in drug-resistant and recurrent symptomatic arrhythmias. ( Millar, RN; Myers, JB; Obel, IW, 1978) |
| "Disopyramide phosphate was administered intravenously to 57 patients with 60 episodes of arrhythmia (21 supraventricular and 39 ventricular) as a 2 mg/kg bolus." | 3.65 | The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate. ( Deano, DA; Ehsani, AI; Mautner, RK; Rosen, KM; Sherman, RH; Wu, D, 1977) |
| "Disopyramide, a new anti-arrhythmic drug, has been assessed in twenty-one episodes of cardiac arrhythmia secondary to acute ischaemic heart disease which failed to respond to more conventional suppressive therapy with lignocaine and other standard drugs." | 3.65 | The use of disopyramide in resistant cardiac arrhythmias due to acute ischaemic heart disease. ( Sandler, G, 1977) |
| "A myocardial infarction model in which infarction is the result of an occluding thrombus was used to evaluate the effectiveness of disopyramide phosphate (DP) in abolishing postinfarction ventricular arrhythmis." | 3.65 | Effects of disopyramide phosphate on ventricular arrhythmias in experimental myocardial infarction. ( Kus, T; Sasyniuk, BI, 1976) |
| " Population pharmacokinetic parameters of DP racemate, enantiomers (S(+)-DP, R(-)-DP), and their unbound concentrations (uDP, S(+)-uDP and R(-)-uDP) were analyzed using the nonlinear mixed effect model (NONMEM) program." | 2.70 | Population pharmacokinetics, protein binding and antiarrhythmic effects of disopyramide enantiomers in arrhythmic patients. ( Aso, R; Katoh, T; Ogata, H; Ohashi, K, 2001) |
| "4." | 2.67 | Anti-arrhythmic properties of the alpha-adrenoceptor blocking drug indoramin. ( James, MA; Jones, JV, 1991) |
| "With disopyramide this increase was not significant." | 2.66 | Comparative study of encainide and disopyramide in chronic ventricular arrhythmias: a double-blind placebo-controlled crossover study. ( Caron, JF; Dupuis, BA; Kacet, S; Kher, AR; Lekieffre, JP; Libersa, CC; Poirier, JM; Wanszelbaum, H, 1985) |
| "Flecainide was as effective as the combination of digoxin and disopyramide and it acted significantly faster and was associated with fewer relapses." | 2.66 | Flecainide compared with a combination of digoxin and disopyramide for acute atrial arrhythmias after cardiopulmonary bypass. ( Campbell, TJ; Gavaghan, TP; Kelly, RP; Koegh, AM; Morgan, JJ; Thorburn, C, 1988) |
| "Moricizine HCl was more effective than propranolol in suppressing VPCs at all individual levels greater than 70% (p less than 0." | 2.66 | Antiarrhythmic efficacy of Ethmozine (moricizine HCl) compared with disopyramide and propranolol. ( Butman, SM; English, LD; Knoll, M; Pratt, CM; Young, JB, 1987) |
| "Propafenone also showed a lower incidence of side effects." | 2.66 | Comparison of propafenone and disopyramide for treatment of chronic ventricular arrhythmias: placebo-controlled, double-blind, randomized crossover study. ( Ambrosioni, E; Bertaccini, P; Bracchetti, D; Cantelli, I; Naccarella, F; Palmieri, M, 1985) |
| " Although both drugs significantly reduced VPDs relative to placebo, ethmozine was a superior antiarrhythmic drug in ach9eving near-total abolition of VPDs (30% of patients), which was never observed during disopyramide dosing (p less than ." | 2.65 | Comparative effect of disopyramide and ethmozine in suppressing complex ventricular arrhythmias by use of a double-blind, placebo-controlled, longitudinal crossover design. ( English, L; Francis, MJ; Kopelen, H; Mann, DE; Norton, HJ; Pratt, CM; Quinones, MA; Roberts, R; Taylor, AA; Young, JB, 1984) |
| " The patients received the appropriate dosage for 7 or more days before repeat radionuclide angiography was performed." | 2.65 | Effects on ventricular function of disopyramide, procainamide and quinidine as determined by radionuclide angiography. ( Gebhardt, VA; Goddard, MD; Gryfe-Becker, B; Nichol, PM; Prato, FS; Rechnitzer, PA; Wisenberg, G; Zawadowski, AG, 1984) |
| " The high incidence of side-effects was probably due to the high dosage used." | 2.65 | Evaluation of the antiarrhythmic efficacy of mexiletine in patients with chronic ventricular arrhythmias. ( Van Durme, JP, 1980) |
| "Out of the 28 severe arrhythmias studied, it was the ventricular extrasystoles which benefited most from treatment (79% completely successful, while there was a lesser degree of success in treating the ventricular tachycardias (35% completely successful, 30% partially successful)." | 2.64 | [Action of injected disopyramide on ventricular arrhythmias and atrioventricular conduction]. ( Bellanger, P; Desoutter, P; Motté, G; Vogel, M; Welti, JJ, 1976) |
| "Disopyramide is a Vaughan-Williams class Ia antiarrhythmic, which is distinguished by its anticholinergic activity, which is due to its active metabolite: mono-N-alkyl disopyramide." | 2.38 | [Effects of disopyramide on normal and pathological atrioventricular conduction]. ( Barnay, C, 1992) |
| " Serious adverse reactions necessitate a change in antiarrhythmic therapy, as opposed to lowering drug dosage to an ineffective level." | 2.37 | Antiarrhythmic drug therapy. Recent advances and current status. ( Somberg, J, 1985) |
| "The frequency of ventricular arrhythmias increases with age." | 2.37 | Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment. ( Morganroth, J; Nestico, PF, 1986) |
| "While treatment of ventricular arrhythmias is completely justifiable for patients with symptoms, their use to prevent sudden cardiac death has not yet been established." | 2.37 | Antiarrhythmic agents for chronic ventricular arrhythmias. ( Morganroth, J; Nestico, PF, 1987) |
| "Disopyramide is a widely used class IA antiarrhythmic drug with a pharmacological profile of action similar to that of quinidine and procainamide." | 2.37 | Disopyramide. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiac arrhythmias. ( Brogden, RN; Todd, PA, 1987) |
| " Special consideration, however, must be given with regard to drug selection and dosage in order to avoid adverse effects on the mother and fetus." | 2.36 | Antiarrhythmic drug therapy during pregnancy. ( Elkayam, U; Frishman, W; Rotmensch, HH, 1983) |
| "Cardiac arrhythmias may be caused by abnormalities of impulse initiation, impulse propagation, or a combination of the two." | 2.36 | Electropharmacology of antiarrhythmic drugs. ( Rosen, MR; Wit, AL, 1983) |
| "Disopyramide is a new antiarrhythmic drug with a pharmacological profile of action similar to that of quinidine and procainamide." | 2.36 | Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias. ( Avery, GS; Brogden, RN; Heel, RC; Speight, TM, 1978) |
| " For this purpose, we plotted a dose-response curve for adrenaline by calculating the arrhythmic ratio, which is the number of ventricular ectopic beats induced by adrenaline divided by the total heart rate, and observed the changes in the arrhythmic ratio-adrenaline dose relation before and after administration of class I drugs." | 1.31 | QT-prolonging class I drug, disopyramide, does not aggravate but suppresses adrenaline-induced arrhythmias. Comparison with cibenzoline and pilsicainide. ( Aye, NN; Hashimoto, K; Miyamoto, S; Teramatsu, T; Zhu, B, 2000) |
| "Disopyramide was metabolized by the cytochrome enzyme CYP3A4 and clarithromycin competitively inhibits this enzyme, probably resulting in an increase in plasma concentration of disopyramide." | 1.30 | Torsades de pointes ventricular tachycardia induced by clarithromycin and disopyramide in the presence of hypokalemia. ( Hashimoto, T; Hayashi, Y; Ikeda, U; Mitsuhashi, T; Shimada, K; Watanabe, T, 1999) |
| " During dosing (10 mg kg-1 twice a day for 10 days) no effects on the electrocardiogram, monitored in conscious animals, were observed despite modest reductions (15-18%) in the maximum rate of depolarization of papillary muscle excised 1 or 6 h after completion of the dosing regime." | 1.28 | Antiarrhythmic, electrophysiological and haemodynamic effects of prolonged oral dosing with Org 7797 in the anaesthetized rat. ( Delbressine, L; Harris, N; Kane, KA; Muir, AW; Winslow, E, 1992) |
| "Moricizine (moracizine) is a new class I antiarrythmic drug which is undergoing a large scale clinical trial at present." | 1.28 | The effect of pretreatment with moricizine on early arrhythmia resulting from myocardial ischemia in rats. ( Hashimoto, K; He, ZS; Komori, S; Tamura, K, 1992) |
| " A sustained-release preparation of DP may be required for pediatric patients to minimize a large fluctuation of plasma drug levels during the dosing intervals." | 1.28 | Steady-state pharmacokinetics and bioavailability of total and unbound disopyramide in children with cardiac arrhythmias. ( Chiba, K; Echizen, H; Ishizaki, T; Ishizawa, A; Koike, K; Nakamoto, M, 1992) |
| "Treatment with aprindine or mexiletine was effective in 7 (50%) of the 14 patients who did not respond to procainamide and/or disopyramide." | 1.28 | Analysis of ventricular arrhythmias in patients with dilated cardiomyopathy--relationship between the effects of antiarrhythmic agents and severity of myocardial lesions. ( Fukuzaki, H; Takarada, A; Yokota, Y, 1990) |
| "The study covered the whole spectrum of cardiac arrhythmias (32 supraventricular, 41 ventricular), and their relation to the autonomic nervous system." | 1.27 | [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases]. ( Assayag, P; Cauchemez, B; Coumel, P; Leclercq, JF; Maisonblanche, P, 1984) |
| "A worsening of arrhythmias was observed in 4/101 (3." | 1.27 | Worsening of arrhythmias during pharmacological treatment. ( Bettini, R; Dal Forno, P; Disertori, M; Furlanello, F; Gramegna, L; Inama, G; Vergara, G, 1984) |
| " C ss and C min were related to AUC60 by the following expressions for both dosage groups: C ss = 0." | 1.27 | Serum disopyramide concentrations and suppression of ventricular premature contractions. ( Dzindzio, BS; Ueda, CT; Vosik, WM, 1984) |
| " This may also explain their poor dose-response relationships and great interindividual variability in plasma concentration data." | 1.27 | Potential applications of free drug level monitoring in cardiovascular therapy. ( Cerskus, I; Roden, DM; Siddoway, LA; Thompson, K; Woosley, RL, 1984) |
| " Searle), literature demonstrating its efficacy in maintaining uniform serum drug levels over a 12-h dosing interval is derived from only normal healthy volunteers." | 1.27 | Serum drug concentrations and adverse effects in cardiac patients after administration of a new controlled-release disopyramide preparation. ( Zema, MJ, 1984) |
| "Phenytoin was effective on three arrhythmias and its min PCs were 9." | 1.27 | Quantitative analysis of the antiarrhythmic effect of drugs on canine ventricular arrhythmias by the determination of minimum effective plasma concentrations. ( Hashimoto, K; Imai, S; Satoh, H; Shibuya, T, 1983) |
| " The bioavailability of disopyramide was the same after capsules and CR tablets." | 1.27 | Plasma concentration of disopyramide given as capsules and controlled release tablets. ( Arnman, K; Graffner, C; Rikner, L; Ryden, L; Voog, L, 1983) |
| "Hypotension and pulmonary edema following intravenous disopyramide is more related to the pharmacology of the drug than to the loading scheme employed." | 1.27 | Safety of multiple bolus loading of intravenous disopyramide. ( Baker, S; Benge, C; Foster, JR; Gettes, LS; Simpson, RJ, 1983) |
| "In four patients with the WPW syndrome and five with VVI pacing, the phase difference between the posterolateral wall of the left ventricle (LV) and the right ventricular apex correlated significantly with the activation time difference between these two regions as assessed by endocardial electrograms (r = 0." | 1.27 | [Gated blood pool imaging in the diagnosis and management of arrhythmia]. ( Kato, R; Kawai, N; Matsushima, H; Okada, M; Sotobata, I; Tanahashi, Y; Yamamoto, S, 1985) |
| "The potential antiarrhythmic and electrophysiological effects of prolonged oral dosing with amiodarone (20 mg/kg/day) or disopyramide (25 or 50 mg/kg b." | 1.27 | Effects of diet-induced hypokalaemia on the antiarrhythmic and electrophysiological actions of prolonged oral treatment with either amiodarone or disopyramide in the anaesthetised rat. ( Hope, FG; Marshall, RJ; Winslow, E, 1987) |
| "Ethacizine was given to 30 patients with chronic ventricular rhythm disorders, including those with frequent extrasystoles, bigeminy, paired extrasystoles and runs of ventricular tachycardia." | 1.27 | [Comparative study of the effectiveness of ethacizine, etmozin and Ritmilen in patients with ventricular rhythmic disorders]. ( Koltunova, MI; Ponomarenko, EL; Shugushev, KhKh; Smetnev, AS, 1987) |
| "Disopyramide was only modestly active, while flecainide and encainide had the least favorable profiles of effect in suppressing re-entry arrhythmias in this model." | 1.27 | Assessment of drug effects on spontaneous and induced ventricular arrhythmias in a 24-h canine infarction model. ( Gomoll, AW, 1987) |
| "In conscious dogs without arrhythmia, SUN 1165 had no deleterious cardiohemodynamic effect and no gross behavioral effect at the oral doses of 3 and 10 mg/kg." | 1.27 | N-(2,6-Dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165): a new potent and long-acting antiarrhythmic agent. ( Aisaka, K; Hamasaki, S; Hidaka, T; Inomata, N; Ishihara, T; Morita, M, 1985) |
| "After treatment of ischemia and/or failure, specific antiarrhythmic agents, conventional and investigational, alone or in combination, are systematically selected." | 1.26 | Ventricular ectopy: etiology, evaluation, and therapy. ( Reid, PR; Vlay, SC, 1982) |
| "In 4 patients who had supraventricular arrhythmias without having either marked prolongation of max SRT or episodes of syncope, disopyramide was administered orally for a long term, during which these arrhythmias and symptoms disappeared and sinus rate increased." | 1.26 | Electrophysiological effects of disopyramide phosphate in patients with sinus node dysfunction. ( Eno, S; Fujitani, K; Furuta, Y; Mitsuda, H; Miyoshi, A; Satou, H; Tateishi, H; Tsuchioka, Y; Yoshida, M, 1982) |
| "Disopyramide was administered in a bolus dose of 2 mg/kg over 10 min with an optional second bolus of 1 mg/kg and infusion of 0." | 1.26 | The antiarrhythmic effect of intravenous disopyramide in an open study. ( Bett, JH; Donnelly, GL; Heddle, WF; Kemp, RJ; Manolas, E; Nelson, GI; Sloman, JG; Tonkin, AM, 1982) |
| " It is suggested that adjustment of dosage is advisable in patients with renal dysfunction or left heart failure." | 1.26 | Study of an anti-arrhythmic agent, disopyramide, in delayed action form ('Ritmoforine' Retard). ( Nauta, IL; van de Calseyde, JF, 1981) |
| "Disopyramide (1." | 1.26 | Effects of intravenous disopyramide on myocardial function in patients with different degrees of cardiac failure. ( Chiariello, M; Condorelli, M; Ferro, G; Santinelli, V; Spinelli, L; Tari, MG, 1980) |
| "In the treatment of extrasystole, the arrhythmia was eliminated or reduced by 75% in 15 of 23 patients." | 1.26 | [Oral longterm therapy with disopyramide phosphate in patients with atrial and ventricular arrhythmias (author's transl)]. ( Grewe, N; Stauch, M, 1977) |
| "Disopyramide has the advantage of being available both as an oral and an intravenous preparation and is a useful drug to be added to the list of more conventional anti-dysrhythmic agents." | 1.26 | Disopyramide--an effective treatment for lignocaine resistant ventricular dysrhythmias. ( Green, AG, 1979) |
| " The dosage should be adapted with respect to the patient's weight and renal function." | 1.26 | [Antiarrhythmic action of disopyramide: a study of plasma levels]. ( Besse, P; Page, A; Pic, A, 1979) |
| "Underventilation and cardiac arrhythmias were observed only in the agonal phase after several minutes of circulatory arrest." | 1.26 | Cardiac consequences and treatment of disopyramide intoxication: experimental evaluation in dogs. ( Hayler, AM; Holt, DW; Medd, RK; O'Keeffe, B, 1979) |
| "Disopyramide has been shown in conditions of cholinergic blockade to have a depressant effect upon sinus node automaticity and the atrial refractoriness." | 1.26 | Dual effect of disopyramide on atrial and atrioventricular conduction and refractory periods. ( Birkhead, JS; Vaughan Williams, EM, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 286 (83.63) | 18.7374 |
| 1990's | 40 (11.70) | 18.2507 |
| 2000's | 13 (3.80) | 29.6817 |
| 2010's | 2 (0.58) | 24.3611 |
| 2020's | 1 (0.29) | 2.80 |
| Authors | Studies |
|---|---|
| Shimoji, Y | 2 |
| Tomita, K | 1 |
| Hashimoto, T | 3 |
| Saito, F | 1 |
| Morisawa, Y | 1 |
| Mizuno, H | 2 |
| Yorikane, R | 2 |
| Koike, H | 2 |
| Kumazawa, T | 1 |
| Harakawa, H | 1 |
| Obase, H | 1 |
| Oiji, Y | 1 |
| Nito, M | 1 |
| Kubo, K | 1 |
| Ishii, A | 1 |
| Tomioka, S | 1 |
| Yamada, Y | 1 |
| Chorvat, RJ | 1 |
| Prodan, KA | 1 |
| Adelstein, GW | 1 |
| Rydzewski, RM | 1 |
| McLaughlin, KT | 1 |
| Stamm, MH | 1 |
| Frederick, LG | 1 |
| Schniepp, HC | 1 |
| Stickney, JL | 1 |
| Johnson, RE | 1 |
| Baizman, ER | 1 |
| Becker, C | 1 |
| Bohnet, EA | 1 |
| Bell, RH | 1 |
| Birsner, NC | 1 |
| Busacca, CA | 1 |
| Carabateas, PM | 1 |
| Chadwick, CC | 1 |
| Gruett, MD | 1 |
| Jia, L | 1 |
| Sun, H | 1 |
| Bai, J | 1 |
| Zhu, Y | 1 |
| Lo, A | 1 |
| Gao, M | 1 |
| Lu, Y | 1 |
| Zhao, J | 1 |
| Zhang, H | 3 |
| Luo, C | 2 |
| Wang, K | 2 |
| Negishi, M | 1 |
| Shimomura, K | 1 |
| Proks, P | 1 |
| Mori, M | 1 |
| Shimomura, Y | 1 |
| Tatarchenko, IP | 1 |
| Pozdniakova, NV | 1 |
| Shevyrev, VA | 1 |
| Morozova, OI | 1 |
| SEKIYA, A | 1 |
| VAUGHANWILLIAMS, EM | 1 |
| Komatsu, T | 1 |
| Yomogida, K | 1 |
| Nakamura, S | 1 |
| Suzuki, O | 1 |
| Horiuchi, D | 1 |
| Kameda, K | 1 |
| Tomita, H | 1 |
| Abe, N | 1 |
| Owada, S | 1 |
| Oikawa, K | 1 |
| Okumura, K | 1 |
| Wakaumi, M | 1 |
| Tsuruoka, S | 1 |
| Sakamoto, K | 1 |
| Shiga, T | 1 |
| Fujimura, A | 1 |
| McPate, MJ | 1 |
| Duncan, RS | 1 |
| Witchel, HJ | 1 |
| Hancox, JC | 1 |
| Dumaine, R | 1 |
| Antzelevitch, C | 1 |
| Schimpf, R | 1 |
| Veltmann, C | 1 |
| Giustetto, C | 1 |
| Gaita, F | 1 |
| Borggrefe, M | 1 |
| Wolpert, C | 1 |
| Opie, LH | 1 |
| Wilcox, RG | 1 |
| Rowley, JM | 1 |
| Hampton, JR | 1 |
| Mitchell, JR | 1 |
| Roland, JM | 1 |
| Banks, DC | 1 |
| Nicholls, DP | 1 |
| Haybyrne, T | 1 |
| Barnes, PC | 1 |
| Gottdiener, JS | 1 |
| DiBianco, R | 1 |
| Fletcher, RD | 1 |
| Leclercq, JF | 2 |
| Georgiopoulos, G | 1 |
| Halkidis, H | 1 |
| Attuel, P | 1 |
| Maisonblanche, P | 2 |
| Coumel, P | 2 |
| Lüderitz, B | 3 |
| Vlay, SC | 1 |
| Reid, PR | 1 |
| Rotmensch, HH | 1 |
| Elkayam, U | 1 |
| Frishman, W | 1 |
| Kuch, J | 1 |
| Berman, ND | 1 |
| De Backer, M | 1 |
| Stoupel, E | 1 |
| Kahn, RJ | 1 |
| Garson, A | 1 |
| Gillette, PC | 1 |
| Wilson, RR | 2 |
| Wallace, AG | 2 |
| Sharma, BD | 1 |
| Chug, S | 1 |
| Mathur, KP | 1 |
| Semel, JD | 1 |
| Wortham, E | 1 |
| Karl, DM | 1 |
| Pratt, CM | 2 |
| Young, JB | 2 |
| Francis, MJ | 1 |
| Taylor, AA | 1 |
| Norton, HJ | 1 |
| English, L | 1 |
| Mann, DE | 1 |
| Kopelen, H | 1 |
| Quinones, MA | 1 |
| Roberts, R | 1 |
| Nigam, P | 1 |
| Khan, S | 1 |
| Singh, R | 1 |
| Kapoor, KK | 1 |
| Kumar, A | 1 |
| Gupta, AK | 1 |
| Chimienti, M | 1 |
| Panciroli, C | 1 |
| Salerno, JA | 1 |
| Regazzi-Bonora, M | 1 |
| Previtali, M | 1 |
| Cristiani, D | 1 |
| Rondanelli, R | 1 |
| Bobba, P | 1 |
| Vaughan Williams, EM | 2 |
| Nappi, JM | 1 |
| Dhanani, S | 1 |
| Lovejoy, JR | 1 |
| VanderArk, C | 1 |
| Arif, M | 1 |
| Laidlaw, JC | 2 |
| Oshrain, C | 2 |
| Willis, PW | 2 |
| Nissen, CH | 1 |
| McDermott, DJ | 1 |
| Smith, WS | 3 |
| Karim, A | 1 |
| Rosen, MR | 2 |
| Wit, AL | 1 |
| Manz, M | 1 |
| Steinbeck, G | 1 |
| Kjekshus, J | 1 |
| Bathen, J | 1 |
| Orning, OM | 1 |
| Storstein, L | 1 |
| Nestico, PF | 4 |
| DePace, NL | 1 |
| Morganroth, J | 4 |
| Assayag, P | 1 |
| Cauchemez, B | 1 |
| Allen-Narker, RA | 1 |
| Roberts, CJ | 1 |
| Marshall, AJ | 1 |
| Jordan, SC | 1 |
| Barritt, DW | 1 |
| Goodfellow, RM | 1 |
| Furlanello, F | 1 |
| Gramegna, L | 1 |
| Dal Forno, P | 1 |
| Vergara, G | 1 |
| Bettini, R | 1 |
| Inama, G | 1 |
| Disertori, M | 1 |
| Hu, BL | 1 |
| Tao, SQ | 1 |
| Liu, LS | 1 |
| Chen, ZJ | 1 |
| Lu, ZL | 1 |
| Wang, J | 1 |
| Ueda, CT | 1 |
| Dzindzio, BS | 1 |
| Vosik, WM | 1 |
| Nolan, MT | 1 |
| Prichard, JS | 1 |
| Liem, KL | 1 |
| Hollander, JM | 1 |
| Stewart, DE | 1 |
| Ikram, H | 1 |
| Nauta, IL | 2 |
| van de Calseyde, J | 1 |
| Hertzberger, DP | 1 |
| Angermann, C | 1 |
| Jahrmärker, H | 1 |
| Ohnishi, K | 1 |
| Akiba, T | 1 |
| Miyake, S | 2 |
| Ajisaka, R | 1 |
| Woosley, RL | 1 |
| Siddoway, LA | 1 |
| Thompson, K | 1 |
| Cerskus, I | 1 |
| Roden, DM | 2 |
| Wisenberg, G | 1 |
| Zawadowski, AG | 1 |
| Gebhardt, VA | 1 |
| Prato, FS | 1 |
| Goddard, MD | 1 |
| Nichol, PM | 1 |
| Rechnitzer, PA | 1 |
| Gryfe-Becker, B | 1 |
| Reddy, CP | 1 |
| Benes, J | 1 |
| Beck, B | 1 |
| Leone, A | 1 |
| Zema, MJ | 1 |
| Kumana, CR | 2 |
| Rambihar, VS | 2 |
| Tanser, PH | 2 |
| Cairns, JA | 2 |
| Gupta, RN | 2 |
| Wildeman, RA | 2 |
| Johnston, M | 2 |
| Johnson, AL | 2 |
| Gent, M | 2 |
| Willis, K | 1 |
| Quevedo, SF | 1 |
| Krauss, DS | 1 |
| Chazan, JA | 1 |
| Crisafulli, FS | 1 |
| Kahn, CB | 1 |
| Singh, BN | 3 |
| Cho, YW | 1 |
| Kuemmerle, HP | 1 |
| Keefe, DL | 2 |
| Kates, RE | 1 |
| Harrison, DC | 2 |
| Flouvat, B | 1 |
| Tsuchioka, Y | 1 |
| Mitsuda, H | 1 |
| Eno, S | 1 |
| Fujitani, K | 1 |
| Furuta, Y | 1 |
| Yoshida, M | 1 |
| Miyoshi, A | 1 |
| Tateishi, H | 1 |
| Satou, H | 1 |
| Kowey, PR | 1 |
| Friedman, PL | 1 |
| Podrid, PJ | 5 |
| Zielonka, J | 1 |
| Lown, B | 2 |
| Wynne, J | 1 |
| Holman, BL | 1 |
| Greene, AC | 1 |
| Iskandrian, AS | 1 |
| Hakki, AH | 1 |
| Kane, SA | 1 |
| Segal, BL | 1 |
| Hashimoto, K | 7 |
| Shibuya, T | 2 |
| Satoh, H | 2 |
| Imai, S | 2 |
| Chiariello, M | 3 |
| Indolfi, C | 1 |
| Cappelli Bigazzi, M | 1 |
| Condorelli, M | 5 |
| Arnman, K | 1 |
| Graffner, C | 1 |
| Rikner, L | 1 |
| Ryden, L | 1 |
| Voog, L | 1 |
| Fukuda, H | 1 |
| Goto, M | 1 |
| Kondo, M | 1 |
| Uchigasaki, T | 1 |
| Sekino, Y | 1 |
| Simpson, RJ | 1 |
| Foster, JR | 1 |
| Benge, C | 1 |
| Baker, S | 1 |
| Gettes, LS | 1 |
| Lien, E | 1 |
| Bakke, OM | 1 |
| Stanford, JL | 1 |
| Felner, JM | 1 |
| Arensberg, D | 1 |
| Manolas, EG | 3 |
| Hunt, D | 3 |
| Sloman, G | 3 |
| Chia, BL | 2 |
| Rubin, IL | 1 |
| Frieden, J | 2 |
| Tonkin, AM | 1 |
| Heddle, WF | 1 |
| Bett, JH | 1 |
| Kemp, RJ | 1 |
| Donnelly, GL | 1 |
| Nelson, GI | 1 |
| Manolas, E | 1 |
| Sloman, JG | 1 |
| Van Durme, JP | 1 |
| Hillson, RM | 1 |
| Boyd, E | 1 |
| Cunningham, J | 1 |
| Rewerski, W | 1 |
| Dorociak, A | 1 |
| Walczak, F | 1 |
| Dobiasz, A | 1 |
| Trimarco, B | 2 |
| Volpe, M | 2 |
| Ricciardelli, B | 2 |
| Sacca', L | 1 |
| De Luca, N | 2 |
| Rengo, F | 2 |
| Silberschmidt, U | 1 |
| Witkowska, M | 1 |
| Morady, F | 1 |
| Scheinman, MM | 3 |
| Desai, J | 1 |
| Drake, CE | 1 |
| Marshall, RJ | 3 |
| Muir, AW | 3 |
| Winslow, E | 4 |
| Norris, RL | 1 |
| Ahokas, JT | 1 |
| Ravenscroft, PJ | 1 |
| Jedlicka, J | 1 |
| Stanĕk, V | 1 |
| Gebauerová, M | 1 |
| Málek, I | 1 |
| Richterová, J | 1 |
| Zeman, S | 1 |
| Böcker, K | 1 |
| Köhler, E | 1 |
| Seipel, L | 1 |
| Loogen, F | 1 |
| Aquaro, G | 2 |
| Belli, R | 1 |
| Pavia, M | 2 |
| Rey, L | 1 |
| Ravera, A | 1 |
| Possavino, G | 1 |
| Idone, P | 1 |
| Ee, BK | 1 |
| Ng, RA | 1 |
| Oh, V | 1 |
| Tan, AT | 1 |
| Choo, M | 1 |
| Bassan, R | 1 |
| Miqueloti, P | 1 |
| de Souza, MA | 1 |
| Luz, FS | 1 |
| Naccarella, F | 3 |
| Palmieri, M | 3 |
| del Corso, P | 1 |
| Lombardi, G | 2 |
| Bracchetti, D | 3 |
| Weber, H | 1 |
| Gloger, D | 1 |
| Joskowicz, G | 1 |
| Steinbach, K | 1 |
| Landmark, K | 2 |
| Bredesen, JE | 1 |
| Thaulow, E | 1 |
| Simonsen, S | 1 |
| Amlie, JP | 1 |
| Hombach, V | 2 |
| Freyland, MD | 2 |
| Steffel, D | 1 |
| Braun, V | 1 |
| Höpp, HW | 1 |
| Zanker, R | 1 |
| Behrenbeck, DW | 2 |
| Tauchert, M | 2 |
| Hilger, HH | 2 |
| Pietro, DA | 1 |
| Bauman, DJ | 1 |
| van de Calseyde, JF | 1 |
| Desai, JM | 1 |
| Hirschfeld, D | 1 |
| Gonzalez, R | 1 |
| Peters, RW | 1 |
| Keren, A | 1 |
| Tzivoni, D | 1 |
| Golhman, JM | 1 |
| Corcos, P | 1 |
| Benhorin, J | 1 |
| Stern, S | 1 |
| Li, JC | 1 |
| D'Ascia, C | 1 |
| Bonaduce, D | 1 |
| Mantovani, B | 1 |
| Schoeneberger, A | 1 |
| Herling, IM | 1 |
| Horowitz, LN | 2 |
| Josephson, ME | 2 |
| Kinney, EL | 1 |
| Field, EH | 1 |
| Salmon, MP | 1 |
| Zelis, R | 1 |
| Ferro, G | 2 |
| Santinelli, V | 2 |
| Tari, MG | 2 |
| Spinelli, L | 1 |
| Meyers, DG | 1 |
| Mohiuddin, SM | 1 |
| Leach, AJ | 1 |
| Brown, JE | 1 |
| Armstrong, PW | 1 |
| Dhurandhar, RW | 1 |
| Lara, M | 1 |
| Oakley, GD | 1 |
| Rowbotham, D | 1 |
| Kimura, E | 1 |
| Mashima, S | 1 |
| Tanaka, T | 2 |
| Kashani, IA | 1 |
| Shakibi, JG | 1 |
| Siassi, B | 1 |
| Patterson, E | 1 |
| Gibson, JK | 1 |
| Lucchesi, BR | 1 |
| Härtel, GU | 1 |
| Haruno, A | 1 |
| Wyse, KR | 1 |
| Ye, V | 1 |
| Campbell, TJ | 2 |
| Komori, S | 2 |
| Sawanobori, T | 1 |
| Tamura, K | 2 |
| Kane, KA | 2 |
| Parratt, JR | 1 |
| Takanaka, C | 1 |
| Lee, JK | 1 |
| Nonokawa, M | 1 |
| Sugiyama, T | 1 |
| Yame, S | 1 |
| Ogawa, S | 3 |
| Mitamura, H | 1 |
| Katoh, H | 1 |
| Sadanaga, T | 2 |
| Okada, Y | 2 |
| Tsutsumi, N | 1 |
| Iwanaga, S | 1 |
| Yoshikawa, T | 1 |
| Akaishi, M | 1 |
| Handa, S | 2 |
| Saikawa, T | 1 |
| Ito, M | 1 |
| Nakagawa, M | 1 |
| Shimoyama, N | 1 |
| Hara, M | 1 |
| Yonemochi, H | 1 |
| Maeda, T | 1 |
| Inoue, T | 2 |
| Takaki, R | 1 |
| Arita, M | 1 |
| Lekieffre, J | 1 |
| Vaur, L | 2 |
| Kacet, S | 2 |
| Lacroix, D | 1 |
| Masuhara, K | 1 |
| Ohno, T | 1 |
| Hamaguchi, K | 1 |
| Katoh, K | 1 |
| Kashiwada, K | 1 |
| Takahashi, S | 1 |
| Tanaka, Y | 1 |
| Someya, K | 1 |
| Ogata, H | 2 |
| Nakamura, M | 1 |
| Xue, Y | 1 |
| Eto, K | 1 |
| Murakami, M | 1 |
| Kinukawa, M | 1 |
| Kanazawa, T | 1 |
| Maruyama, K | 1 |
| Miyagi, M | 1 |
| Miyata, H | 1 |
| Ujiie, A | 1 |
| Pernat, A | 1 |
| Pohar, B | 1 |
| Horvat, M | 1 |
| Yoshida, K | 1 |
| Kimura, K | 1 |
| Hibi, K | 1 |
| Nemoto, T | 1 |
| Iwasawa, Y | 1 |
| Hongo, Y | 1 |
| Sugiyama, M | 1 |
| Ishikawa, T | 1 |
| Kuji, N | 1 |
| Tochikubo, O | 1 |
| Ishii, M | 1 |
| Tachibana, H | 2 |
| Yamaki, M | 2 |
| Kubota, I | 2 |
| Watanabe, T | 3 |
| Yamauchi, S | 2 |
| Tomoike, H | 2 |
| Hayashi, Y | 2 |
| Ikeda, U | 1 |
| Mitsuhashi, T | 1 |
| Shimada, K | 1 |
| Hidaka, T | 2 |
| Komoriya, K | 1 |
| Inomata, N | 2 |
| Miyamoto, S | 1 |
| Zhu, B | 1 |
| Teramatsu, T | 1 |
| Aye, NN | 1 |
| Aso, R | 1 |
| Ohashi, K | 1 |
| Katoh, T | 1 |
| Donaldson, RM | 1 |
| Carson, IW | 1 |
| Lyons, SM | 1 |
| Shanks, RG | 1 |
| Nisbet, T | 1 |
| Dreifus, LS | 1 |
| Jennings, G | 2 |
| Jones, MS | 1 |
| Besterman, EM | 4 |
| Model, DG | 1 |
| Turner, PP | 1 |
| Kidner, PH | 6 |
| Ward, JW | 2 |
| Vogel, M | 1 |
| Desoutter, P | 1 |
| Bellanger, P | 1 |
| Motté, G | 1 |
| Welti, JJ | 1 |
| Padfield, PL | 1 |
| Smith, DA | 1 |
| Fitzsimons, EJ | 1 |
| McCruden, DC | 1 |
| Perroni, GB | 1 |
| Briguglio, FS | 1 |
| Oddo, A | 1 |
| Trovato, G | 1 |
| Zainal, N | 2 |
| Carmichael, DJ | 3 |
| Griffiths, JW | 1 |
| Gillham, AD | 1 |
| Summers, GD | 1 |
| Stauch, M | 1 |
| Grewe, N | 1 |
| Green, AG | 1 |
| Ruffy, R | 1 |
| Zipes, DP | 2 |
| Page, A | 1 |
| Pic, A | 1 |
| Besse, P | 1 |
| Ross, D | 1 |
| Vohra, J | 2 |
| Cole, P | 1 |
| Hulting, J | 4 |
| Jansson, B | 1 |
| Pouleur, H | 1 |
| Chaudron, JM | 1 |
| Reyns, P | 1 |
| Ankier, SI | 1 |
| Heel, RC | 1 |
| Brogden, RN | 2 |
| Speight, TM | 1 |
| Avery, GS | 1 |
| Myburgh, DP | 1 |
| Goldman, AP | 1 |
| Sequeira, M | 1 |
| Luria, MH | 1 |
| Koch-Weser, J | 1 |
| Nicholson, WJ | 1 |
| Martin, CE | 1 |
| Gracey, JG | 1 |
| Knoch, HR | 1 |
| Rosenhamer, G | 3 |
| Story, JR | 1 |
| Abdulla, AM | 1 |
| Frank, MJ | 1 |
| Shaxted, EJ | 1 |
| Milton, PJ | 1 |
| Collins, SM | 1 |
| Arzbaecher, RC | 1 |
| Tri, TB | 1 |
| González Maqueda, I | 1 |
| García Fernández, F | 1 |
| Martin Jadraque, L | 1 |
| López Sendon, JL | 1 |
| Coma Canella, I | 1 |
| Levites, R | 1 |
| Anderson, GJ | 1 |
| Sbarbaro, JA | 1 |
| Rawling, DA | 1 |
| Fozzard, HA | 1 |
| Cooper, D | 1 |
| Fox, K | 1 |
| Evans, T | 1 |
| Rowland, E | 1 |
| Krikler, D | 1 |
| Hayes, JG | 1 |
| Ahmad, S | 1 |
| Sheikh, AI | 1 |
| Meeran, MK | 1 |
| Dibble, JB | 1 |
| Webster, NR | 1 |
| O'Keeffe, B | 1 |
| Hayler, AM | 2 |
| Holt, DW | 2 |
| Medd, RK | 1 |
| Stanislao, M | 1 |
| Hung, D | 1 |
| Dowling, JT | 2 |
| Luxton, M | 2 |
| Vohra, JK | 1 |
| Berthoumieu, F | 1 |
| Henry, E | 1 |
| Glovaez, D | 1 |
| Desrez, X | 1 |
| Pradere, B | 1 |
| Fournial, G | 1 |
| Gaillard, J | 1 |
| Anderson, JL | 2 |
| Meffin, PJ | 1 |
| Winkle, RA | 1 |
| Goldman, P | 1 |
| Ingelfinger, JA | 1 |
| Mason, DT | 2 |
| Leonard, RF | 1 |
| Braun, TE | 1 |
| Levy, AM | 1 |
| Bellows, JG | 1 |
| Rozanski, JJ | 1 |
| Castellanos, A | 2 |
| Sung, RJ | 1 |
| Myerburg, RJ | 1 |
| Conrad, ME | 1 |
| Cumbie, WG | 1 |
| Thrasher, DR | 1 |
| Carpenter, JT | 1 |
| Hespe, I | 1 |
| Gil-Sanchez, D | 1 |
| Krüger, H | 1 |
| Wolff, HH | 1 |
| Marx-Heep, I | 1 |
| Adams, HJ | 1 |
| Bennett, DH | 1 |
| Cosma, C | 1 |
| Pauly-Laubry, C | 1 |
| Py, J | 1 |
| Myers, JB | 1 |
| Millar, RN | 1 |
| Obel, IW | 1 |
| LaBarre, A | 1 |
| Strauss, HC | 1 |
| Evans, GT | 1 |
| Bashore, T | 1 |
| Tiedeman, JS | 1 |
| Yu, PN | 1 |
| Niarchos, AP | 1 |
| Danilo, P | 1 |
| Jones, B | 1 |
| Model, D | 1 |
| Turner, P | 1 |
| Jutzy, RV | 1 |
| Pugh, DM | 1 |
| Jones, TE | 1 |
| Nagle, RE | 1 |
| Deano, DA | 1 |
| Wu, D | 1 |
| Mautner, RK | 1 |
| Sherman, RH | 1 |
| Ehsani, AI | 1 |
| Rosen, KM | 1 |
| Birkhead, JS | 1 |
| Sandler, G | 1 |
| Garcia, BD | 1 |
| Perez, T | 1 |
| Nieto, LK | 1 |
| Hillis, WS | 1 |
| Tweddel, A | 1 |
| Lorimer, AR | 1 |
| Lawrie, TD | 1 |
| Mizgala, HF | 1 |
| Huvelle, PR | 1 |
| Jones, MB | 1 |
| Hohansson, BW | 1 |
| Persson, S | 1 |
| Vandenbosch, R | 2 |
| Lisin, N | 2 |
| Andriange, M | 2 |
| Gach, J | 1 |
| Carlier, J | 2 |
| Vismara, L | 1 |
| Berman, R | 1 |
| Fowler, NO | 1 |
| Befeler, B | 3 |
| Caracta, A | 1 |
| Kalmansohn, RG | 1 |
| Cook, WR | 1 |
| Turiel, SN | 1 |
| Dean, RR | 1 |
| Wells, DE | 1 |
| Vagueiro, MC | 1 |
| Yeh, BK | 1 |
| Nakamura, T | 1 |
| Takahashi, K | 1 |
| Niitani, U | 1 |
| Sugiura, T | 1 |
| Miyaji, K | 1 |
| Chien, YW | 1 |
| Lambert, HJ | 1 |
| Lin, TK | 1 |
| Casedevant, B | 1 |
| Sabaut, D | 1 |
| Clementy, J | 1 |
| Dallocchio, M | 1 |
| Gilgenkrantz, JM | 1 |
| Aliot, E | 1 |
| Maureira, JJ | 1 |
| Olbermann, M | 1 |
| Just, H | 1 |
| Guckenbiehl, H | 1 |
| Lang, KF | 1 |
| Kus, T | 1 |
| Sasyniuk, BI | 1 |
| Barnay, C | 1 |
| Delbressine, L | 1 |
| Harris, N | 1 |
| Perederiĭ, VG | 1 |
| Nikitin, AV | 1 |
| Zemskov, AM | 1 |
| Gusmanov, VA | 1 |
| Liberman, VM | 1 |
| Kuroda, T | 1 |
| Yoshihara, Y | 1 |
| Nakamura, H | 1 |
| Azumi, T | 1 |
| Inatome, T | 1 |
| Fukuzaki, H | 2 |
| Takanashi, H | 1 |
| Yogo, K | 1 |
| Akima, M | 1 |
| He, ZS | 1 |
| Chiba, K | 1 |
| Koike, K | 1 |
| Nakamoto, M | 1 |
| Echizen, H | 1 |
| Ishizawa, A | 1 |
| Ishizaki, T | 1 |
| James, MA | 2 |
| Jones, JV | 1 |
| Kurakina, TI | 2 |
| Gorshkov, VA | 2 |
| Nesvetov, VN | 1 |
| Itoh, Y | 1 |
| Shiga, H | 1 |
| Kumakura, S | 1 |
| Fukami, M | 1 |
| Romanò, M | 1 |
| Spinelli, A | 1 |
| Cazzani, E | 1 |
| Muzio, L | 1 |
| Stanton, MS | 1 |
| Brembilla-Perrot, B | 1 |
| Tanabe, T | 3 |
| Suzuki, M | 1 |
| Prystowsky, EN | 2 |
| Waldo, AL | 1 |
| Fisher, JD | 2 |
| Kurbanov, RD | 2 |
| Dabrowski, A | 1 |
| Ostrowska, B | 1 |
| Bacior, B | 1 |
| Fryśna-Dmuchowska, B | 1 |
| Kargul, W | 1 |
| Król, J | 1 |
| Królikowski, Z | 1 |
| Luczak, D | 1 |
| Malczewska, B | 1 |
| Nessler, J | 1 |
| Oźarek-Medyńska, T | 1 |
| Krynicki, M | 1 |
| Polubiec, A | 1 |
| Akiyama, K | 1 |
| Takarada, A | 1 |
| Yokota, Y | 1 |
| Yamamoto, S | 1 |
| Kawai, N | 1 |
| Okada, M | 1 |
| Matsushima, H | 1 |
| Kato, R | 1 |
| Sotobata, I | 1 |
| Tanahashi, Y | 1 |
| Somberg, JC | 1 |
| Miura, D | 1 |
| Greenspan, AM | 1 |
| Spielman, SR | 1 |
| Hope, FG | 1 |
| Penkov, N | 1 |
| Mitkova, M | 1 |
| Kaponov, Kh | 1 |
| Karastatev, D | 1 |
| Smetnev, AS | 2 |
| Ponomarenko, EL | 1 |
| Koltunova, MI | 1 |
| Shugushev, KhKh | 1 |
| Ragosta, M | 1 |
| Weihl, AC | 1 |
| Rosenfeld, LE | 1 |
| Yoshikawa, H | 2 |
| Tagawa, R | 1 |
| Furuya, H | 2 |
| Ide, M | 1 |
| Goto, Y | 2 |
| Caron, JF | 1 |
| Libersa, CC | 1 |
| Kher, AR | 1 |
| Wanszelbaum, H | 1 |
| Dupuis, BA | 1 |
| Poirier, JM | 1 |
| Lekieffre, JP | 1 |
| Onoda, N | 1 |
| Kawagoe, M | 1 |
| Shimizu, M | 1 |
| Komori, T | 1 |
| Takahashi, C | 1 |
| Oomori, Y | 1 |
| Hirata, Y | 1 |
| Zadionchenko, VS | 1 |
| Vladimirova, LM | 1 |
| Smirnov, VK | 1 |
| Ivashchuk, AG | 1 |
| Terekhova, TM | 1 |
| Troshina, EV | 1 |
| Vladimirov, PV | 1 |
| Sliuniastikov, MA | 1 |
| Liusov, VA | 1 |
| Dudaev, VA | 1 |
| Borodkin, VV | 1 |
| Rudakov, AV | 1 |
| Bunin, IuA | 2 |
| Smirnov, IE | 1 |
| Asymbekova, EU | 2 |
| Savchenko, AP | 1 |
| Somberg, J | 1 |
| Rønnevik, PK | 1 |
| Gundersen, T | 1 |
| Abrahamsen, AM | 1 |
| Kim, SG | 1 |
| Mercando, AD | 1 |
| Tam, S | 1 |
| Bauman, JL | 1 |
| Gallastegui, J | 1 |
| Strasberg, B | 1 |
| Swiryn, S | 1 |
| Hoff, J | 1 |
| Welch, WJ | 1 |
| Bauernfeind, RA | 1 |
| Huang, SK | 1 |
| Marcus, FI | 1 |
| Paulk, EA | 1 |
| Sherashov, VS | 1 |
| Solov'eva, FV | 1 |
| Priori, SG | 1 |
| Bonazzi, O | 1 |
| Facchini, M | 1 |
| Varisco, T | 1 |
| Schwartz, PJ | 1 |
| Gomoll, AW | 1 |
| Gavaghan, TP | 1 |
| Koegh, AM | 1 |
| Kelly, RP | 1 |
| Thorburn, C | 1 |
| Morgan, JJ | 1 |
| Pomerantsev, EV | 1 |
| Firstova, MI | 1 |
| Bakashvili, NG | 1 |
| Denniss, AR | 1 |
| Ross, DL | 1 |
| Cody, DV | 1 |
| Russell, PA | 1 |
| Young, AA | 1 |
| Richards, DA | 1 |
| Uther, JB | 1 |
| Gimrikh, EO | 1 |
| Gushchin, IV | 1 |
| Chekhov, AM | 1 |
| Popov, SV | 1 |
| Mikhaĭlenko, AI | 1 |
| Kobayashi, A | 1 |
| Watanabe, H | 1 |
| Yamazaki, N | 1 |
| Kiiakbaev, GK | 1 |
| Jonason, T | 1 |
| Ringqvist, I | 1 |
| Bandh, S | 1 |
| Nilsson, G | 1 |
| Nilsson, H | 1 |
| Lidell, C | 1 |
| Bjerle, P | 1 |
| Olofsson, BO | 1 |
| Rabkin, SW | 1 |
| Boroomand-Rashti, K | 1 |
| McKinnon, J | 1 |
| Rotem, CE | 1 |
| Todd, PA | 1 |
| Butman, SM | 1 |
| Knoll, M | 1 |
| English, LD | 1 |
| Capparelli, EV | 1 |
| DiPersio, DM | 1 |
| Zhao, H | 1 |
| Kluger, J | 1 |
| Chow, MS | 1 |
| Minardo, JD | 1 |
| Heger, JJ | 1 |
| Miles, WM | 1 |
| Kadowaki, Y | 1 |
| Ohta, T | 1 |
| Hotokebuchi, N | 1 |
| Kimoto, S | 1 |
| Haruna, M | 1 |
| Nakao, T | 1 |
| Ueda, M | 1 |
| Nishi, K | 1 |
| Rohla, M | 1 |
| Balázsi, I | 1 |
| Ekelund, LG | 1 |
| Nilsson, E | 1 |
| Walldius, G | 1 |
| Pedersen-Bjergaard, O | 1 |
| Lindeneg, O | 1 |
| Svendsen, TL | 1 |
| Enk, B | 1 |
| Fridberg, M | 1 |
| Ribeiro, C | 1 |
| Longo, A | 1 |
| Sakai, K | 1 |
| Yamazaki, T | 1 |
| Takagi, M | 1 |
| Kusumoto, M | 1 |
| Miyazawa, Y | 1 |
| Umemura, J | 1 |
| Suwa, J | 1 |
| Komatsu, Y | 1 |
| Doviner, AD | 1 |
| Zolotov, NA | 1 |
| Merzon, AK | 1 |
| Papouchado, M | 1 |
| Vann Jones, J | 1 |
| Cantelli, I | 1 |
| Bertaccini, P | 1 |
| Ambrosioni, E | 1 |
| Grosu, AA | 1 |
| Carrasco, HA | 1 |
| Vicuña, AV | 1 |
| Molina, C | 1 |
| Landaeta, A | 1 |
| Reynosa, J | 1 |
| Vicuña, N | 1 |
| Fuenmayor, A | 1 |
| López, F | 1 |
| Antiuf'ev, VF | 1 |
| Arkhipov, MV | 1 |
| Bychkova, MA | 1 |
| Härtel, G | 1 |
| Kushakovskiĭ, MS | 1 |
| Uzilevskaia, RA | 1 |
| Baker, EJ | 1 |
| Curry, PV | 1 |
| Tynan, M | 1 |
| Aisaka, K | 1 |
| Hamasaki, S | 1 |
| Ishihara, T | 1 |
| Morita, M | 1 |
| Bleifer, DJ | 1 |
| Hansmann, DR | 1 |
| Bleifer, SB | 1 |
| Sheppard, JS | 1 |
| Karpman, HL | 1 |
| Hauswirth, O | 1 |
| Casagrande, C | 1 |
| Galli, A | 1 |
| Ferrini, R | 1 |
| Miragoli, G | 1 |
| Ferrari, G | 1 |
| Sanna, GP | 1 |
| Lomanto, B | 1 |
| Rossi, A | 1 |
| Woyda, J | 1 |
| Pellegrino, L | 1 |
| Di Michele, A | 1 |
| Prencipe, D | 1 |
| Caracta, AR | 1 |
| Lau, SH | 1 |
| Gallagher, JJ | 1 |
| Damato, AN | 1 |
| Dzieglielewski, T | 1 |
| Wachowiak, A | 1 |
| Doshchitsin, VL | 1 |
| Golovina, TN | 1 |
| Osipova, TN | 1 |
| Lotto, A | 1 |
| Graziina, A | 1 |
| Rota, M | 1 |
| Cavallaro, GF | 1 |
| Greco, EM | 1 |
| De Thomatis, M | 1 |
| Vismara, LA | 1 |
| Amsterdam, EA | 1 |
| Poletti, T | 1 |
| D'Arrigo, A | 1 |
33 reviews available for disopyramide and Arrhythmia
| Article | Year |
|---|---|
Effects of antiarrhythmic agents on cardiac function.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Arrhythmias, Car | 1982 |
Antiarrhythmic drug therapy during pregnancy.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Breast Feeding; Digitalis | 1983 |
Disopyramide: six years' experience.
Topics: Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyramide; Double-Blind Method; Humans; Parasympa | 1983 |
Disopyramide.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Electrocardiograph | 1984 |
Electropharmacology of antiarrhythmic drugs.
Topics: Action Potentials; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide | 1983 |
Therapy with conventional antiarrhythmic drugs for ventricular arrhythmias.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Heart Ventricles; Hu | 1984 |
New insights into the drug treatment of ventricular arrhythmias.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Disopyramide; Humans; Kinetics; L | 1984 |
New antiarrhythmic drugs: their place in therapy.
Topics: Action Potentials; Ajmaline; Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Aprindine; Arrhy | 1981 |
[Clinical pharmacology of disopyramide].
Topics: Arrhythmias, Cardiac; Biological Availability; Clinical Trials as Topic; Disopyramide; Dose-Response | 1980 |
[Disopyramide poisoning].
Topics: Acid-Base Equilibrium; Arrhythmias, Cardiac; Disopyramide; Heart Ventricles; Hemoperfusion; Humans; | 1981 |
[Clinical pharmacology of anti-arrhythmia agents. I. Quinidine, procainamide and disopyramide].
Topics: Arrhythmias, Cardiac; Biological Availability; Disopyramide; Half-Life; Humans; Intestinal Absorptio | 1981 |
Disopyramide.
Topics: Arrhythmias, Cardiac; Disopyramide; Drug Interactions; Electrophysiology; Heart; Heart Block; Humans | 1982 |
Anti-arrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Anesthetics; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dis | 1979 |
Disopyramide--a review.
Topics: Arrhythmias, Cardiac; Disopyramide; Hemodynamics; Humans; Kinetics; Pyridines | 1977 |
Rational basis of antiarrhythmic therapy: clinical pharmacology of commonly used antiarrhythmic drugs.
Topics: Action Potentials; Anesthetics, Local; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calciu | 1978 |
Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias.
Topics: Arrhythmias, Cardiac; Disopyramide; Drug Interactions; Electrophysiology; Heart; Hemodynamics; Human | 1978 |
Cardiac effects of disopyramide.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Atrioventricular Node; Clinical Trials as Topic; D | 1976 |
[Effects of disopyramide on normal and pathological atrioventricular conduction].
Topics: Arrhythmias, Cardiac; Disopyramide; Electrophysiology; Heart Conduction System; Humans | 1992 |
[Efficacy and tolerance of disopyramide in arrhythmia associated with sinus node dysfunction].
Topics: Aged; Arrhythmias, Cardiac; Atropine; Bradycardia; Disopyramide; Electrocardiography, Ambulatory; El | 1991 |
[Comparative characteristics of arrhythmogenic effects of anti-arrhythmia agents].
Topics: Aconitine; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Electrocardiograp | 1991 |
Comparisons of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Double-Blind Method; Encainide | 1990 |
The role of antiarrhythmic drugs in prevention of sudden cardiac death.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Cardiac Comple | 1985 |
The treatment of ventricular rhythm disturbances.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premat | 1986 |
Combination antiarrhythmic drug therapy for ventricular tachyarrhythmias.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; | 1986 |
Antiarrhythmic drug therapy. Recent advances and current status.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrh | 1985 |
Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
Topics: Aged; Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Digox | 1986 |
Antiarrhythmic drug therapy of ventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Flecaini | 1986 |
Antiarrhythmic agents for chronic ventricular arrhythmias.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Encainide; Flecain | 1987 |
Disopyramide. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiac arrhythmias.
Topics: Arrhythmias, Cardiac; Disopyramide; Humans; Kinetics | 1987 |
Procainamide and disopyramide.
Topics: Arrhythmias, Cardiac; Disopyramide; Humans; Kinetics; Procainamide | 1987 |
[Disopyramide phosphate: the electrophysiological mechanisms of its anti-arrhythmia action and its use in clinical practice].
Topics: Animals; Arrhythmias, Cardiac; Atrioventricular Node; Disopyramide; Dogs; Electrophysiology; Heart; | 1985 |
[Disopyramide: its mechanisms of action and clinical use].
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Drug Evaluation; D | 1985 |
Comparative mechanisms of action of antiarrhythmic drugs.
Topics: Action Potentials; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzof | 1974 |
68 trials available for disopyramide and Arrhythmia
| Article | Year |
|---|---|
Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction.
Topics: Acute Disease; Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Clinical Trials as Topic; Disopyra | 1980 |
Intravenous and oral disopyramide after myocardial infarction.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Di | 1980 |
Disopyramide: six years' experience.
Topics: Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyramide; Double-Blind Method; Humans; Parasympa | 1983 |
Effect of oral disopyramide on mortality and extension of infarction in cases of acute myocardial infarction admitted to open wards.
Topics: Administration, Oral; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyramide; Electrocar | 1983 |
Comparative effect of disopyramide and ethmozine in suppressing complex ventricular arrhythmias by use of a double-blind, placebo-controlled, longitudinal crossover design.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyramide; D | 1984 |
Chemoprophylaxis of arrhythmias with oral disopyramide in acute myocardial infarction.
Topics: Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyramide; Fem | 1983 |
Dihydroquinidine versus disopyramide: efficacy in patients with chronic stable ventricular ectopy.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Chronic Disease; Clinical Trials as Topic; Disopyrami | 1984 |
A randomized, double-blind, parallel group comparison of disopyramide phosphate and quinidine in patients with cardiac arrhythmias.
Topics: Administration, Oral; Adolescent; Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Disop | 1983 |
[Long-term drug therapy in ventricular cardiac arrhythmias. Is an improvement of the prognosis possible?].
Topics: Adult; Aged; Amiodarone; Aprindine; Arrhythmias, Cardiac; Disopyramide; Humans; Long-Term Care; Mexi | 1983 |
Prophylaxis against ventricular arrhythmias in suspected acute myocardial infarction: a comparison of tocainide and disopyramide.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Female; Humans; Lidocaine; Male; Middle | 1984 |
Plasma levels of disopyramide after administration of conventional capsules and sustained-release tablets.
Topics: Adult; Aged; Arrhythmias, Cardiac; Capsules; Delayed-Action Preparations; Disopyramide; Double-Blind | 1983 |
[Comparative studies on the cardiodepressant effect of disopyramide, mexiletine and propafenon].
Topics: Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Echocardiography; Female; Heart R | 1983 |
Effects on ventricular function of disopyramide, procainamide and quinidine as determined by radionuclide angiography.
Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiac Output; Disopyramide; Female; Heart; Hemodynamics; Humans | 1984 |
A placebo-controlled study to determine the efficacy of oral disopyramide phosphate for the prophylaxis of ventricular dysrhythmias after acute myocardial infarction.
Topics: Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyramide; Double-Blind Method; Fema | 1982 |
Absorption and antidysrhythmic activity of oral disopyramide phosphate after acute myocardial infarction.
Topics: Adult; Aged; Arrhythmias, Cardiac; Body Weight; Clinical Trials as Topic; Disopyramide; Double-Blind | 1982 |
Prajmalium bitartrate in chronic ventricular arrhythmias: comparison with disopyramide.
Topics: Adult; Aged; Ajmaline; Arrhythmias, Cardiac; Disopyramide; Drug Evaluation; Electrocardiography; Fem | 1983 |
Effects of quinidine and disopyramide on serum digoxin concentrations.
Topics: Adult; Aged; Arrhythmias, Cardiac; Digoxin; Disopyramide; Drug Interactions; Female; Humans; Male; M | 1980 |
Evaluation of the antiarrhythmic efficacy of mexiletine in patients with chronic ventricular arrhythmias.
Topics: Arrhythmias, Cardiac; Atenolol; Chronic Disease; Clinical Trials as Topic; Disopyramide; Double-Blin | 1980 |
Prophylactic disopysramide: its clinical effects related to plasma concentration in myocardial infarction.
Topics: Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyramide; Double-Blind Method; Fema | 1980 |
[Clinical pharmacology of disopyramide].
Topics: Arrhythmias, Cardiac; Biological Availability; Clinical Trials as Topic; Disopyramide; Dose-Response | 1980 |
Disopyramide and mexiletine: which is the agent of choice in the long term-oral treatment of lidocaine-responsive arrhythmias? Efficacy comparison in a randomized trial.
Topics: Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyramide; Electrocardiography; Humans; Lidocaine | 1980 |
Comparison of the efficacy of propafenone versus disopyramide for complex premature ventricular contractions. Evaluation with long-term monitoring.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chronic Disease; Disopyramide | 1982 |
[Efficacy and tolerability of sustained-release disopyramide in the treatment of cardiac arrhythmia. Results of a study with 593 patients].
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Delayed-Action Preparations; Disopyramide; Dru | 1993 |
Relationship between the therapeutic effects or side-effects and the serum disopyramide or mono-N-dealkylated disopyramide concentration after repeated oral administration of disopyramide to arrhythmic patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chromatography, High P | 1995 |
Population pharmacokinetics, protein binding and antiarrhythmic effects of disopyramide enantiomers in arrhythmic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bayes Theo | 2001 |
Clinical studies of Norpace (Part XI).
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic | 1975 |
Oral disopyramide in prophylaxis of arrhythmias following myocardial infarction.
Topics: Administration, Oral; Arrhythmias, Cardiac; Atrial Fibrillation; Clinical Trials as Topic; Disopyram | 1976 |
[Action of injected disopyramide on ventricular arrhythmias and atrioventricular conduction].
Topics: Aged; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Disopyramide; Dr | 1976 |
Arrhythmia prevention in early myocardial infarction.
Topics: Administration, Oral; Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyramide; Drug Therapy, Co | 1977 |
Oral disopyramide for the prevention of arrhythmias in patients with acute myocardial infarction admitted to open wards.
Topics: Acute Disease; Administration, Oral; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyram | 1977 |
Clinical studies of Norpace (Part IX).
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Diarrhea; Disopyramide; Drug | 1975 |
Antiarrhythmic and electrocardiographic effects of single oral doses of disopyramide.
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Creatinine; Disopyrami | 1977 |
Effects of disopyramide and aprindine on arrhythmias after acute myocardial infarction.
Topics: Acute Disease; Adult; Aged; Aprindine; Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyramide; | 1977 |
The anti-arrhythmic efficacy of perhexiline maleate, disopyramide and mexiletine in ventricular ectopic activity.
Topics: Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyramide; Heart V | 1978 |
Suppression of ventricular arrhythmias with intravenous disopyramide and lidocaine: efficacy comparison in a randomized trial.
Topics: Acute Disease; Adult; Aged; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Humans; Injections | 1979 |
Disopyramide: serum level and arrhythmia conversion.
Topics: Administration, Oral; Aged; Arrhythmias, Cardiac; Biopharmaceutics; Blood Pressure; Clinical Trials | 1976 |
Cardiac effects of disopyramide.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Atrioventricular Node; Clinical Trials as Topic; D | 1976 |
Disopyramide in the treatment and prevention of arrhythmias following myocardial infarction.
Topics: Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyramide; Humans; Myocardial Infarction; Pyridin | 1976 |
Clinical studies of Norpace (Part IV).
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Clinical Trials as T | 1975 |
Clinical studies of Norpace (Part VI).
Topics: Adult; Anti-Arrhythmia Agents; Anticoagulants; Arrhythmias, Cardiac; Bradycardia; Clinical Trials as | 1975 |
Disopyramide in patients with ventricular premature beats: an experimental model and preliminary results.
Topics: Adult; Aged; Arrhythmias, Cardiac; Disopyramide; Electrocardiography; Heart Ventricles; Humans; Meth | 1976 |
Clinical studies of Norpace (Part I).
Topics: Administration, Oral; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Capsules; Clinical Trials as Top | 1975 |
Clinical studies of Norpace (Part II).
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyramide; D | 1975 |
Clinical studies of Norpace (Part VII).
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyramide; Drug Evaluatio | 1975 |
Clinical studies of Norpace (Part VIII).
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Clinical Trials as Topic; D | 1975 |
Clinical studies of Norpace. Summarizing remarks.
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; At | 1975 |
Anti-arrhythmic properties of the alpha-adrenoceptor blocking drug indoramin.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramid | 1991 |
[Delayed-action disopyramide in the treatment of hyperkinetic ventricular arrhythmia. A randomized clinical comparative study vs immediate-action disopyramide].
Topics: Aged; Arrhythmias, Cardiac; Delayed-Action Preparations; Disopyramide; Electrocardiography, Ambulato | 1991 |
Use of disopyramide by arrhythmia specialists after Cardiac Arrhythmia Suppression Trial: patient selection and initial outcome.
Topics: Arrhythmias, Cardiac; Data Collection; Delayed-Action Preparations; Disopyramide; Drug Therapy, Comb | 1991 |
Comparisons of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Double-Blind Method; Encainide | 1990 |
The role of antiarrhythmic drugs in prevention of sudden cardiac death.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Cardiac Comple | 1985 |
Combination antiarrhythmic drug therapy for ventricular tachyarrhythmias.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; | 1986 |
Comparative study of encainide and disopyramide in chronic ventricular arrhythmias: a double-blind placebo-controlled crossover study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardia | 1985 |
[Palpitin in disorders of cardiac rhythm].
Topics: Aged; Arrhythmias, Cardiac; Capsules; Clinical Trials as Topic; Disopyramide; Dose-Response Relation | 1989 |
Tolerability and antiarrhythmic efficacy of disopyramide compared to lignocaine in selected patients with suspected acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Arrhythmias, Cardiac; Disopyramide; Drug Therapy, Combination; Fe | 1987 |
Flecainide compared with a combination of digoxin and disopyramide for acute atrial arrhythmias after cardiopulmonary bypass.
Topics: Acute Disease; Aged; Arrhythmias, Cardiac; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Clin | 1988 |
Randomized controlled trial of prophylactic antiarrhythmic therapy in patients with inducible ventricular tachyarrhythmias after recent myocardial infarction.
Topics: Actuarial Analysis; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Electric Stimu | 1988 |
Propafenone versus disopyramide for treatment of chronic symptomatic ventricular arrhythmias. A multicenter study.
Topics: Adult; Aged; Arrhythmias, Cardiac; Chronic Disease; Clinical Trials as Topic; Disopyramide; Electroc | 1988 |
Comparison of propafenone and disopyramide in the treatment of ventricular premature complexes: a randomized double blind crossover placebo controlled trial.
Topics: Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyramide; Double-Blind Method; Gastrointestinal | 1987 |
Antiarrhythmic efficacy of Ethmozine (moricizine HCl) compared with disopyramide and propranolol.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyramide; D | 1987 |
Efficacy of and adverse effects of disopyramide. Comparison of capsules, controlled release tablets and placebo in patients with chronic ventricular arrhythmias.
Topics: Aged; Arrhythmias, Cardiac; Blood Pressure; Capsules; Chronic Disease; Clinical Trials as Topic; Del | 1986 |
[Disopyramide and lignocaine in the treatment of ventricular arrhythmia in patients with acute ischemic heart disease].
Topics: Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Coronary Disease; Disopyramide; Double-Blind M | 1986 |
Comparison of propafenone and disopyramide for treatment of chronic ventricular arrhythmias: placebo-controlled, double-blind, randomized crossover study.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyramide; D | 1985 |
Effect of low oral doses of disopyramide and amiodarone on ventricular and atrial arrhythmias of chagasic patients with advanced myocardial damage.
Topics: Administration, Oral; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Chagas Cardiomyopa | 1985 |
[Use of ritmilen in disorders of cardiac rhythm].
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Ascorbic Acid; Clinical Trials as Topic; Disopyramide; Drug | 1985 |
[Trial of the clinical use of Ritmilen].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyram | 1985 |
Disopyramide (Rythmodan) for arrhythmias?
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Disopyramide; Human | 1973 |
Disopyramide phosphate: clinical efficacy of a new oral antiarrhythmic drug.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzothiadiazines; Digoxin; Disopyramide; | 1974 |
247 other studies available for disopyramide and Arrhythmia
| Article | Year |
|---|---|
Synthesis and biological action of the aminotetrahydroisoquinocarbazoles and related compounds: a new class of compounds with antiarrhythmic activity.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Carbazoles; Chloroform; Do | 1992 |
Synthesis and antiarrhythmic activity of 5,11-dihydro[1]benzoxepino[3,4-b]pyridines.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzoxepins; Chemical Phenomena; Chemistry; C | 1990 |
Synthesis and structure-activity relationships of a new series of antiarrhythmic agents: 4,4-disubstituted hexahydro-3H-pyrido[1,2-c]pyrimidin-3-ones and related compounds.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Brain; Chemical Phenomena; Chemistry; Depression, Che | 1985 |
4,5-Dihydro-1-phenyl-1H-2,4-benzodiazepines: novel antiarrhythmic agents.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzodiazepines; Cats; Disease Models, Animal | 1993 |
Support vector machines classification of hERG liabilities based on atom types.
Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant | 2008 |
In Silico Assessment of Class I Antiarrhythmic Drug Effects on
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Computer Simulation; Dis | 2021 |
In silico assessment of the effects of quinidine, disopyramide and E-4031 on short QT syndrome variant 1 in the human ventricles.
Topics: Action Potentials; Arrhythmias, Cardiac; Cell Line; Disopyramide; Electrocardiography; ERG1 Potassiu | 2017 |
Modelling the effects of quinidine, disopyramide, and E-4031 on short QT syndrome variant 3 in the human ventricles.
Topics: Action Potentials; Arrhythmias, Cardiac; Disopyramide; Heart Conduction System; Heart Defects, Conge | 2017 |
Mechanism of disopyramide-induced hypoglycaemia in a patient with Type 2 diabetes.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Ang | 2009 |
[Anti-arrhythmic therapy: diagnostic possibilities of signal-averaged electrocardiography and heart rate variability].
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Data I | 2003 |
THE EFFECTS OF PRONETHALOL, DICHLOROISOPRENALINE AND DISOPYRAMIDE ON THE TOXICITY TO THE HEART OF OUABAIN AND ANAESTHETICS.
Topics: Anesthetics; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Brugada Syndrome; Cardiac | 1963 |
[Relationship between duration of arrhythmia and subsequent preventive effect of disopyramide after cardioversion in patients with symptomatic paroxysmal and persistent atrial fibrillation].
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Disopyramide; Electric Coun | 2003 |
Pilsicainide in breast milk from a mother: comparison with disopyramide and propafenone.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Breast Feeding; Disopyramide; Female; Humans; Lidocain | 2005 |
Disopyramide is an effective inhibitor of mutant HERG K+ channels involved in variant 1 short QT syndrome.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; CHO Cells; Cricetinae; Cricetulus; Death, Sud | 2006 |
Disopyramide: although potentially life-threatening in the setting of long QT, could it be life-saving in short QT syndrome?
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Disopyramide; Drug Interaction | 2006 |
In vivo effects of mutant HERG K+ channel inhibition by disopyramide in patients with a short QT-1 syndrome: a pilot study.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Diarrhea; Disopyramide; ERG1 Potassium Ch | 2007 |
Drugs and the heart. IV. Antiarrhythmic agents.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Br | 1980 |
[Effects of anti-arrhythmia agents on heart rate. Significance and importance].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibril | 1981 |
[Typical risks in the treatment of arrhythmias].
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Diagnostic Errors; Disopy | 1982 |
Ventricular ectopy: etiology, evaluation, and therapy.
Topics: Adrenergic beta-Antagonists; Amiodarone; Angina Pectoris; Anti-Arrhythmia Agents; Aprindine; Arrhyth | 1982 |
[Pharmacological treatment of arrhythmia].
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; | 1983 |
Ventricular tachycardia initiated by both normally and aberrantly conducted atrial premature beats.
Topics: Aged; Arrhythmias, Cardiac; Bundle-Branch Block; Cardiac Complexes, Premature; Cardiac Pacing, Artif | 1980 |
Efficacy of intravenous disopyramide in acute cardiac arrhythmias.
Topics: Acute Disease; Adolescent; Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; C | 1981 |
Treatment of chronic ventricular dysrhythmias in the young.
Topics: Administration, Oral; Adolescent; Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Child, | 1981 |
[Drug therapy of arrhythmia in coronary cardiopathy].
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Cardiac Comp | 1983 |
Fasting hypoglycemia associated with disopyramide.
Topics: Aged; Arrhythmias, Cardiac; Disopyramide; Humans; Hypoglycemia; Insulin; Male | 1983 |
Severe hypoglycemia associated with disopyramide.
Topics: Aged; Arrhythmias, Cardiac; Disopyramide; Humans; Hypoglycemia; Male; Pyridines | 1983 |
A double-blind, crossover comparison of flecainide acetate and disopyramide phosphate in the treatment of ventricular premature complexes.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Disopyramide; Double-Blin | 1984 |
[Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Elect | 1984 |
Worsening of arrhythmias during pharmacological treatment.
Topics: Adolescent; Adult; Aged; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzene | 1984 |
[Clinical observations on effects of disopyramide on arrhythmias].
Topics: Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Disopyramide; Drug Resistance; Female; Huma | 1981 |
Serum disopyramide concentrations and suppression of ventricular premature contractions.
Topics: Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Biological Availability; Chromatography, Ga | 1984 |
Non-fatal overdose with disopyramide.
Topics: Adolescent; Arrhythmias, Cardiac; Disopyramide; Dopamine; Female; Humans; Suicide, Attempted | 1984 |
Maintenance therapy after i.v. administration of disopyramide with an oral sustained release preparation, a pharmacokinetic study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Arrhythmias, Cardiac; Delayed-Action Preparations; Di | 1984 |
The use of intravenous disopyramide for the conversion of supraventricular tachyarrhythmias.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Disopyramide; Dr | 1984 |
[Case of disopyramide-induced hypoglycemia].
Topics: Aged; Arrhythmias, Cardiac; Disopyramide; Humans; Hypoglycemia; Male | 1983 |
Potential applications of free drug level monitoring in cardiovascular therapy.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Binding Sites; Blood Proteins; Cardiovascular Agents; | 1984 |
Intravenous disopyramide: safety and efficacy of a new dosage regimen.
Topics: Adult; Aged; Arrhythmias, Cardiac; Disopyramide; Dose-Response Relationship, Drug; Drug Evaluation; | 1984 |
[Use of intravenous disopyramide in the treatment of symptomatic refractory ventricular arrhythmia].
Topics: Adult; Aged; Arrhythmias, Cardiac; Disopyramide; Drug Evaluation; Female; Heart Ventricles; Humans; | 1984 |
Serum drug concentrations and adverse effects in cardiac patients after administration of a new controlled-release disopyramide preparation.
Topics: Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Delayed-Action Preparations; Diarrhea; Diso | 1984 |
Fasting hypoglycemia secondary to disopyramide therapy. Report of two cases.
Topics: Aged; Arrhythmias, Cardiac; Blood Glucose; Disopyramide; Fasting; Female; Humans; Hypoglycemia; Male | 1981 |
Clinical pharmacology of antiarrhythmic drugs: a review and overview, part II.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Humans; | 1981 |
[Determination of plasma concentrations of anti-arrhythmia agents].
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Biological Availability; Disopyramide; Dose-Response R | 1981 |
Electrophysiological effects of disopyramide phosphate in patients with sinus node dysfunction.
Topics: Arrhythmias, Cardiac; Disopyramide; Electric Stimulation; Electrocardiography; Female; Heart Rate; H | 1982 |
Use of radionuclide ventriculography for assessment of changes in myocardial performance induced by disopyramide phosphate.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Disopyramide; Female; Heart; Heart Diseases; Humans; | 1982 |
Effect of oral disopyramide therapy on left ventricular function.
Topics: Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Cardiac Output; Cardiac Vol | 1983 |
Quantitative analysis of the antiarrhythmic effect of drugs on canine ventricular arrhythmias by the determination of minimum effective plasma concentrations.
Topics: Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Dogs; Female; Lidoca | 1983 |
Plasma concentration of disopyramide given as capsules and controlled release tablets.
Topics: Adult; Aged; Arrhythmias, Cardiac; Biological Availability; Capsules; Delayed-Action Preparations; D | 1983 |
[Effects of lorcainide, a new antiarrhythmic agent, on experimental cardiac arrhythmias].
Topics: Acetylcholine; Aconitine; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; | 1983 |
Safety of multiple bolus loading of intravenous disopyramide.
Topics: Adult; Aged; Arrhythmias, Cardiac; Disopyramide; Electrocardiography; Female; Hemodynamics; Humans; | 1983 |
Sustained release disopyramide compared to plain capsules after change-over from intravenous infusion.
Topics: Adult; Aged; Arrhythmias, Cardiac; Biological Availability; Capsules; Delayed-Action Preparations; D | 1983 |
Antiarrhythmic drug therapy.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Digitalis Glycosides; Disopyramid | 1980 |
Disopyramide induced atypical ventricular tachycardia.
Topics: Administration, Oral; Aged; Arrhythmias, Cardiac; Disopyramide; Electrocardiography; Female; Heart V | 1980 |
Electrocardiograms of the month. Arrhythmia.
Topics: Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Disopyramide; Electrocardiography; Female; Heart; H | 1980 |
The antiarrhythmic effect of intravenous disopyramide in an open study.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Coronary Care Units; Disopyramide; Drug Evaluation; F | 1982 |
Cardiac drug overdose.
Topics: Arrhythmias, Cardiac; Bretylium Compounds; Cardiovascular Agents; Cardiovascular Diseases; Digoxin; | 1982 |
The effects of postligation administration of ORG 6001 and disopyramide on early ischaemia-induced arrhythmias in the anaesthetized rat.
Topics: Androstanols; Anesthesia; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Cor | 1982 |
Simultaneous high-performance liquid chromatographic assay for quinidine, disopyramide and the mono-N-dealkylated metabolite of disopyramide.
Topics: Arrhythmias, Cardiac; Chromatography, High Pressure Liquid; Disopyramide; Humans; Pyridines; Quinidi | 1982 |
[The antiarrhythmic effect of intravenously administered disopyramide].
Topics: Arrhythmias, Cardiac; Disopyramide; Humans; Injections, Intravenous; Pyridines | 1982 |
Canine-effective plasma concentrations of antiarrhythmic drugs on the two-stage coronary ligation arrhythmia.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Vessels; Disopyramide; Dogs; Dose-Re | 1982 |
[The effect of disopyramide, mexiletine and propafenon after intravenous and oral administration on left ventricular function in the M-mode echocardiogram].
Topics: Administration, Oral; Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Drug Therap | 1982 |
[Intravenously disopyramide phosphate administration for treatment of arrhythmias].
Topics: Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Disopyramide; Drug Evaluation; Electrocardiograph | 1982 |
Acute termination of cardiac arrhythmias with intravenous disopyramide.
Topics: Adult; Aged; Arrhythmias, Cardiac; Disopyramide; Electrocardiography; Female; Humans; Male; Middle A | 1982 |
[Hemodynamic effects of oral disopyramide in patients with acute myocardial infarction].
Topics: Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Disopyramide; Female; Heart Rate; Humans; Male; M | 1982 |
[Quantitative evaluation of an antiarrhythmic therapy (disopyramide) in patients with frequent premature ventricular contractions (PVC) using a computer-assisted long-term ECG analysis system (author's transl)].
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Circadian Rhythm; Computers; Disopyramide; Electrocar | 1981 |
Pharmacokinetics of disopyramide in patients with imminent to moderate cardiac failure.
Topics: Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Biological Availability; Disopyramide; Fema | 1981 |
[Clinical experiences with the antiarrhythmic therapy using disopyramide].
Topics: Adult; Aged; Arrhythmias, Cardiac; Disopyramide; Electrocardiography; Female; Humans; Male; Middle A | 1981 |
Thioridazine-associated ventricular tachycardia and isoproterenol.
Topics: Aged; Arrhythmias, Cardiac; Disopyramide; Hemodynamics; Humans; Male; Pyridines | 1981 |
Myocardial depression with disopyramide.
Topics: Aged; Arrhythmias, Cardiac; Disopyramide; Hemodynamics; Humans; Male; Pyridines | 1981 |
Study of an anti-arrhythmic agent, disopyramide, in delayed action form ('Ritmoforine' Retard).
Topics: Aged; Arrhythmias, Cardiac; Delayed-Action Preparations; Disopyramide; Electrocardiography; Female; | 1981 |
Cardiovascular collapse associated with disopyramide therapy.
Topics: Administration, Oral; Aged; Arrhythmias, Cardiac; Disopyramide; Electrocardiography; Female; Heart A | 1981 |
Development of a severe model of early coronary artery ligation-induced dysrhythmias in the anaesthetized rat.
Topics: Androstanols; Angiotensin II; Animals; Arrhythmias, Cardiac; Atropine; Catecholamines; Coronary Vess | 1981 |
Ventricular pacing in atypical ventricular tachycardia.
Topics: Aged; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Disopyramide; Electrocardiography; Female; H | 1981 |
[Clinical efficacy of disopyramide in the treatment of cardiac arrhythmias (author's transl)].
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Child; Disopyramide; Female; Humans; Male; Middle Age | 1980 |
[Efficacy of disopyramide and mexiletine per os in the chronic treatment of ventricular arrhythmias sensitive to lidocaine].
Topics: Arrhythmias, Cardiac; Disopyramide; Humans; Lidocaine; Mexiletine; Middle Aged; Propylamines; Pyridi | 1981 |
[Evaluation of the efficacy of anti-arrhythmia agents in hyperkinetic ventricular arrhythmia].
Topics: Administration, Oral; Arrhythmias, Cardiac; Disopyramide; Drug Evaluation; Electrophysiology; Heart | 1980 |
Congestive heart failure caused by oral disopyramide.
Topics: Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Disopyramide; Female; Heart Failure; Humans | 1980 |
Ventricular ectopic activity after medical and surgical treatment for recurrent sustained ventricular tachycardia.
Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Disopyramide; Electrocardiography; Fe | 1980 |
Cardiac arrhythmias associated with disopyramide.
Topics: Aged; Arrhythmias, Cardiac; Disopyramide; Humans; Male; Middle Aged; Pyridines; Retrospective Studie | 1980 |
Effects of intravenous disopyramide on myocardial function in patients with different degrees of cardiac failure.
Topics: Arrhythmias, Cardiac; Coronary Disease; Depression, Chemical; Disopyramide; Humans; Injections, Intr | 1980 |
Efficacy of disopyramide phosphate in the treatment of refractory ventricular arrhythmias.
Topics: Aged; Arrhythmias, Cardiac; Disopyramide; Heart Ventricles; Humans; Male; Middle Aged; Pyridines | 1980 |
Cardiac depression by intravenous disopyramide in patients with left ventricular dysfunction.
Topics: Aged; Arrhythmias, Cardiac; Blood Pressure; Depression, Chemical; Disopyramide; Female; Heart; Heart | 1980 |
Disopyramide-induced ventricular arrhythmia.
Topics: Arrhythmias, Cardiac; Disopyramide; Heart Ventricles; Humans; Pyridines | 1980 |
Potentially dangerous effect of disopyramide on atrioventricular conduction in a patient on digitalis.
Topics: Aged; Arrhythmias, Cardiac; Atrioventricular Node; Digitalis Glycosides; Disopyramide; Female; Heart | 1980 |
Clinical evaluation of antiarrhythmic effects of disopyramide by multiclinical controlled double-blind methods.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Disopyramide; Double-Blind Method; Drug Evaluation; Human | 1980 |
Electrophysiologic effects of disopyramide in children.
Topics: Adolescent; Arrhythmias, Cardiac; Atropine; Child; Child, Preschool; Disopyramide; Female; Heart Con | 1980 |
Electrophysiologic effects of disopyramide phosphate on reentrant ventricular arrhythmia in conscious dogs after myocardial infarction.
Topics: Animals; Arrhythmias, Cardiac; Disopyramide; Dogs; Electrophysiology; Heart Conduction System; Heart | 1980 |
[The new antiarrhythmia drugs disopyramide and mexiletine].
Topics: Arrhythmias, Cardiac; Disopyramide; Humans; Mexiletine; Propylamines; Pyridines | 1980 |
Antiarrhythmic effects of bisaramil on triggered arrhythmias produced by intracoronary injection of digitalis and adrenaline in the dog.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bridged Bicyclo Compounds, Heterocyclic; Chlo | 1995 |
Action potential prolongation exhibits simple dose-dependence for sotalol, but reverse dose-dependence for quinidine and disopyramide: implications for proarrhythmia due to triggered activity.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Cesium; Disopyramide; Dogs; Dose-Response Relation | 1993 |
Effects of NS-2, a new class 1 antiarrhythmic agent, and AFD-19, its active metabolite, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats: comparison with disopyramide and mexiletine.
Topics: Amino Alcohols; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Coronary Dise | 1994 |
Frequency dependent effects of class I antiarrhythmic agents studied in patients with implanted pacemakers.
Topics: Aged; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Cross-Ove | 1994 |
Effect of E-4031, a new class III antiarrhythmic drug, on reentrant ventricular arrhythmias: comparison with conventional class I drugs.
Topics: Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disease Models, Animal; Disopyrami | 1993 |
Clinical evaluation of the use-dependent QRS prolongation and the reverse use-dependent QT prolongation of class I and class III antiarrhythmic agents and their value in predicting efficacy.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Drug Evaluation; Electrocar | 1993 |
Suppression of ventricular premature contractions continues after the washout of antiarrhythmic drugs.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atenolol; Disopyramide; Electrocardiograp | 1993 |
Antiarrhythmic effects of optical isomers of disopyramide on canine ventricular arrhythmias.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Digitali | 1996 |
Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory act
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cyclooxygenase | 1996 |
Heart conduction disturbances and cardiovascular collapse after disopyramide and low-dose metoprolol in a patient with hypertrophic obstructive cardiomyopathy.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiomyopathy, Hypertrophic; Dis | 1997 |
[A patient with disopyramide intoxication rescued by percutaneous cardiopulmonary support].
Topics: Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Assisted Circulation; Disopyramide; Humans; Hyp | 1998 |
Intracoronary flecainide induces ST alternans and reentrant arrhythmia on intact canine heart: A role of 4-aminopyridine-sensitive current.
Topics: 4-Aminopyridine; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Vessels; Disopyrami | 1999 |
Torsades de pointes ventricular tachycardia induced by clarithromycin and disopyramide in the presence of hypokalemia.
Topics: Aged; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Arrhythmias, Cardiac; Clarithromycin; Cytochrom | 1999 |
[Antiarrhythmic effects of pilsicainide hydrochloride and effects on cardiac function and ECG in dogs: comparison with disopyramide].
Topics: Anesthesia; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Vessels; Disease Models, | 2000 |
Anisotropic effects of sodium channel blockers on the wavelength for ventricular excitation in dogs.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Dogs; Electr | 2000 |
QT-prolonging class I drug, disopyramide, does not aggravate but suppresses adrenaline-induced arrhythmias. Comparison with cibenzoline and pilsicainide.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Disopyramide; Dogs; Drug Inte | 2000 |
Disopyramide: interactions with marcolide antibiotics.
Topics: Anti-Arrhythmia Agents; Anti-Bacterial Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Disop | 2001 |
The treatment of supraventricular arrhythmias.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Arrhyt | 1979 |
Clinical studies of Norpace (Part X).
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Complexes | 1975 |
Letter: Disopyramide dose.
Topics: Arrhythmias, Cardiac; Disopyramide; Humans; Pyridines | 1976 |
Disopyramide and acute psychosis.
Topics: Aged; Arrhythmias, Cardiac; Disopyramide; Female; Humans; Psychoses, Substance-Induced; Pyridines | 1977 |
[Data on disopyridamide therapy of some arrhythmias].
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Complexes, Premature; Disopyramid | 1977 |
Disopyramide for cardiac arrhythmias.
Topics: Arrhythmias, Cardiac; Disopyramide; Drug Evaluation; Humans; Pyridines | 1977 |
Disopyramide in myocardial infarction.
Topics: Aged; Arrhythmias, Cardiac; Disopyramide; Drug Evaluation; Humans; Middle Aged; Myocardial Infarctio | 1977 |
[Oral longterm therapy with disopyramide phosphate in patients with atrial and ventricular arrhythmias (author's transl)].
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Complexes, Premature; Di | 1977 |
Disopyramide in myocardial infarction.
Topics: Arrhythmias, Cardiac; Disopyramide; Humans; Myocardial Infarction; Pyridines | 1978 |
Disopyramide dialysability.
Topics: Arrhythmias, Cardiac; Disopyramide; Gastric Lavage; Half-Life; Hemoperfusion; Humans; Pyridines; Ren | 1978 |
Disopyramide--an effective treatment for lignocaine resistant ventricular dysrhythmias.
Topics: Arrhythmias, Cardiac; Cardiac Complexes, Premature; Disopyramide; Female; Humans; Lidocaine; Male; M | 1979 |
Preventing ventricular arrhythmias in ischemic heart disease.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Humans; Lidocaine; Nitroglyce | 1979 |
[Antiarrhythmic action of disopyramide: a study of plasma levels].
Topics: Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Disopyramide; Dose-Response Relationship, D | 1979 |
Drugs used in the care of the cardiac patient.
Topics: Anticoagulants; Antihypertensive Agents; Arrhythmias, Cardiac; Atropine; Bretylium Tosylate; Cardiac | 1978 |
Electrophysiology of disopyramide in man.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Atrioventricular Node; Disopyramide; Electrocardiogra | 1978 |
Clinical experience with disopyramide.
Topics: Adult; Aged; Arrhythmias, Cardiac; Disopyramide; Female; Humans; Male; Middle Aged; Pyridines | 1979 |
Disopyramide.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chemical Phenomena; Chemistry; Disopyramide; Heart; He | 1979 |
Disopyramide-induced ventricular fibrillation.
Topics: Administration, Oral; Aged; Arrhythmias, Cardiac; Disopyramide; Electrocardiography; Female; Heart B | 1979 |
Kinetics of hemodynamic and electrocardiographic changes following intravenous disopyramide.
Topics: Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Chromatography, Gas; Disopyramide; Dose-Response | 1979 |
Cardiogenic shock and disopyramide phosphate.
Topics: Acute Disease; Arrhythmias, Cardiac; Cardiac Output; Disopyramide; Heart Failure; Humans; Kidney Fai | 1979 |
Disopyramide in pregnancy: a case report.
Topics: Adult; Arrhythmias, Cardiac; Disopyramide; Electrocardiography; Female; Heart Rate; Humans; Pregnanc | 1979 |
Feedback control in the management of cardiac arrhythmias.
Topics: Animals; Arrhythmias, Cardiac; Computers; Disopyramide; Dogs; Electrocardiography; Feedback; Infusio | 1979 |
Disopyramide-induced syncope.
Topics: Arrhythmias, Cardiac; Disopyramide; Female; Humans; Pyridines; Quinidine; Syncope | 1979 |
[Electrophysiological interrelations of disopyramide with atropine].
Topics: Arrhythmias, Cardiac; Atropine; Disopyramide; Drug Evaluation; Drug Interactions; Electrophysiology; | 1979 |
Electrophysiological effects of disopyramide phosphate during experimental myocardial ischemia.
Topics: Animals; Arrhythmias, Cardiac; Arterial Occlusive Diseases; Coronary Disease; Coronary Vessels; Diso | 1979 |
Cardiac arrhythmias.
Topics: Arrhythmias, Cardiac; Disopyramide; Humans; Pyridines | 1979 |
'Bradycardia-tachycardia' syndrome 8 yr after correction of Fallot's tetralogy.
Topics: Adolescent; Arrhythmias, Cardiac; Atrial Flutter; Bradycardia; Child; Child, Preschool; Death, Sudde | 1979 |
Disopyramide.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Disopyramide; Humans; Male; Middle Aged; Pyridines | 1979 |
Disopyramide-induced acute psychosis.
Topics: Aged; Arrhythmias, Cardiac; Disopyramide; Female; Humans; Panic; Psychoses, Substance-Induced; Pyrid | 1979 |
Adverse reaction to disopyramide.
Topics: Arrhythmias, Cardiac; Disopyramide; Electrocardiography; Female; Humans; Hypotension; Injections, In | 1979 |
Cardiac consequences and treatment of disopyramide intoxication: experimental evaluation in dogs.
Topics: Animals; Arrhythmias, Cardiac; Disopyramide; Dogs; Dopamine; Electrocardiography; Glucagon; Heart Ar | 1979 |
[Clinical and hemodynamic effects of disopyramide phosphate administered i.v. in cardiopathic subjects (author's transl)].
Topics: Adult; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Electrocardiography; Female; Heart Rate | 1979 |
Collapse after oral disopyramide.
Topics: Adult; Aged; Arrhythmias, Cardiac; Disopyramide; Female; Humans; Male; Middle Aged; Pyridines; Shock | 1979 |
Disopyramide (Norpace) for ventricular arrhythmias.
Topics: Arrhythmias, Cardiac; Disopyramide; Heart Ventricles; Humans; Pyridines | 1977 |
[Disopyramide: a new antiarrhythmic drug].
Topics: Animals; Arrhythmias, Cardiac; Disopyramide; Humans; Pyridines | 1977 |
Quinidine effects due to disopyramide.
Topics: Aged; Arrhythmias, Cardiac; Disopyramide; Electrocardiography; Female; Heart; Humans; Pyridines; Ven | 1978 |
[Cardiac rhythm disorders after pneumonectomy. Attempted prevention].
Topics: Administration, Oral; Arrhythmias, Cardiac; Digitalis Glycosides; Disopyramide; Drug Evaluation; Hum | 1978 |
Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.
Topics: Acebutolol; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Bretylium Compounds | 1978 |
Therapy with antiarrhythmic drugs.
Topics: Acetylation; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Heart Failure; Humans; Indo | 1978 |
Disopyramide: a new agent for effective therapy of ventricular dysrhythmias.
Topics: Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Electrocardiography; Humans; Pyridines | 1978 |
Initiation of uterine contractions by disopyramide during pregnancy.
Topics: Adult; Arrhythmias, Cardiac; Disopyramide; Female; Heart Valve Diseases; Humans; Mitral Valve; Pregn | 1978 |
Cardiac dysrhythmias.
Topics: Arrhythmias, Cardiac; Disopyramide; Humans; Quinidine; Sulfinpyrazone | 1978 |
Disopyramide and quinidine.
Topics: Arrhythmias, Cardiac; Disopyramide; Female; Humans; Middle Aged; Pyridines; Quinidine | 1978 |
Agranulocytosis associated with disopyramide therapy.
Topics: Agranulocytosis; Arrhythmias, Cardiac; Disopyramide; Drug Hypersensitivity; Humans; Male; Middle Age | 1978 |
[Electrophysiological effects of disopyramide on the specialized cardiac conduction system in man (author's transl)].
Topics: Adult; Aged; Arrhythmias, Cardiac; Bundle of His; Cardiac Pacing, Artificial; Disopyramide; Electroc | 1978 |
Oral disopyramide in the prevention of ventricular arrhythmias following myocardial infarction in patients managed on the coronary care unit and open ward.
Topics: Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Coronary Care Units; Disopyramide; Female; | 1978 |
Treatment of cardiac arrhythmias. Part II--The drugs.
Topics: Arrhythmias, Cardiac; Bretylium Compounds; Digitalis Glycosides; Disopyramide; Electric Countershock | 1978 |
[Experiences with disopyramide in arrhythmias. Results of a broad spectrum evaluation by private physicians].
Topics: Arrhythmias, Cardiac; Disopyramide; Drug Evaluation; Humans; Pyridines | 1978 |
Disopyramide in patients with the Wolff-Parkinson-White syndrome and atrial fibrillation.
Topics: Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Disopyramide; Female; Heart Ventricles; Huma | 1978 |
[Electrocardiographic disturbances induced by the simultaneous administration of indapamide and disopyramide].
Topics: Arrhythmias, Cardiac; Disopyramide; Diuretics; Drug Therapy, Combination; Electrocardiography; Human | 1978 |
Clinical and electrophysiological observations with disopyramide in drug-resistant and recurrent symptomatic arrhythmias.
Topics: Adult; Aged; Arrhythmias, Cardiac; Depression, Chemical; Disopyramide; Drug Resistance; Electrophysi | 1978 |
Electrophysiologic effects of disopyramide phosphate on sinus node function in patients with sinus node dysfunction.
Topics: Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Atrioventricular Node; Bradycardia; Cardiac | 1979 |
Disopyramide phosphate (Norpace): a new antiarrhythmic drug.
Topics: Administration, Oral; Arrhythmias, Cardiac; Disopyramide; Drug Evaluation; Half-Life; Heart Conducti | 1979 |
Collapse after oral administration of disopyramide.
Topics: Abdomen; Arrhythmias, Cardiac; Disopyramide; Humans; Hypotension; Pain; Pyridines; Venous Pressure | 1979 |
Effect of intravenous disopyramide on premature beats.
Topics: Arrhythmias, Cardiac; Disopyramide; Humans; Infusions, Parenteral; Pyridines | 1977 |
The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.
Topics: Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Disopy | 1977 |
Dual effect of disopyramide on atrial and atrioventricular conduction and refractory periods.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Atrioventricular Node; Atropine; Disopyramide; Female | 1977 |
Disopyramide for arrhythmias.
Topics: Arrhythmias, Cardiac; Disopyramide; Humans; Pyridines | 1977 |
The use of disopyramide in resistant cardiac arrhythmias due to acute ischaemic heart disease.
Topics: Acute Disease; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Humans; Pyridines | 1977 |
[Effect of disopyramide on the sino-atrial node].
Topics: Animals; Arrhythmias, Cardiac; Disopyramide; Dogs; Female; Male; Pyridines; Sinoatrial Node | 1976 |
Some aspects of the clinical pharmacology of intravenous disopyramide after myocardial infarction.
Topics: Arrhythmias, Cardiac; Blood Pressure; Disopyramide; Electrocardiography; Heart Rate; Humans; Injecti | 1976 |
Acute termination of cardiac arrhythmias with intravenous disopyramide.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Disopyramide; Humans; Injections, Intravenous; Middle | 1976 |
The use of disopyramide in the treatment of arrhythmias in ambulatory patients.
Topics: Adult; Aged; Ambulatory Care; Arrhythmias, Cardiac; Disopyramide; Electrocardiography; Heart Atria; | 1976 |
Anti-arrhythmic and haemodynamic effects of intravenous and oral disopyramide in patients with ventricular arrhythmia.
Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Dis | 1976 |
[Clinical experimentation with intravenously administered disopyramide].
Topics: Adult; Aged; Arrhythmias, Cardiac; Disopyramide; Drug Evaluation; Female; Humans; Injections, Intrav | 1975 |
The hemodynamic effects of Norpace. (Part II).
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Cardiac Catheterization; Cardiac Outpu | 1975 |
The electrophysiology of Norpace (Part II).
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrioventricular Node; Disopyramide; Drug Evaluation; | 1975 |
The electrophysiology of Norpace (Part III).
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrioventricular Node; Bundle of His; Chronaxy; Disopy | 1975 |
Clinical studies of Norpace (Part III).
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Drug Evaluation; Female; Follow-Up | 1975 |
Clinical studies of Norpace (Part V).
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Drug Evaluation; Female; Hu | 1975 |
A seminar on Norpace (disopyramide phosphate) a new antiarrhythmic agent. Introductory remarks.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Drug Evaluation; Drug Evaluatio | 1975 |
The pharmacology of Norpace.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Atrioven | 1975 |
The hemodynamic effects of Norpace (Part I).
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Cardiac Output; Chromatog | 1975 |
Electrophysiologic effects of the antiarrhythmic agent disopyramide phosphate.
Topics: Adult; Age Factors; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Bundle-Branch Block; Coronary D | 1975 |
[Proceedings: Anti-arrhythmic action of disopyramide].
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Heart Rate; Humans; Pyridines; | 1975 |
Linear relationships between plasma binding and lipophilicity of disopyramide derivatives.
Topics: Arrhythmias, Cardiac; Blood Proteins; Disopyramide; Drug Interactions; Humans; In Vitro Techniques; | 1975 |
[Letter: Syncopes through the inversion of points in connection with the absorption of disopyramide].
Topics: Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Female; Humans; Hypertension; Hypokalemia; Mid | 1975 |
[Indications and surveillance of quinidine and disopyramide treatments].
Topics: Arrhythmias, Cardiac; Disopyramide; Humans; Pyridines; Quinidine | 1975 |
[Anti-arrhythmia effect of disopyramide].
Topics: Adult; Aged; Arrhythmias, Cardiac; Disopyramide; Heart Conduction System; Humans; Male; Middle Aged; | 1975 |
Hemodynamic and electrocardiographic effects of disopyramide in patients with ventricular arrhythmia.
Topics: Arrhythmias, Cardiac; Blood Pressure; Cardiac Output; Central Venous Pressure; Depression, Chemical; | 1976 |
Effects of disopyramide phosphate on ventricular arrhythmias in experimental myocardial infarction.
Topics: Animals; Arrhythmias, Cardiac; Bundle of His; Disopyramide; Dogs; Electrocardiography; Female; Heart | 1976 |
[Clinical significance of the use-dependent sodium channel block and reverse use-dependent potassium channel block of class I and class III antiarrhythmic agents and their values to predict drug efficacy].
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Drug Evaluation; Electrocardiography, Am | 1992 |
Antiarrhythmic, electrophysiological and haemodynamic effects of prolonged oral dosing with Org 7797 in the anaesthetized rat.
Topics: Action Potentials; Administration, Oral; Anesthesia; Animals; Anti-Arrhythmia Agents; Arrhythmias, C | 1992 |
[The immunological changes in patients with idiopathic ventricular arrhythmias].
Topics: Adjuvants, Immunologic; Adult; Arrhythmias, Cardiac; Disopyramide; Drug Evaluation; Drug Therapy, Co | 1992 |
Effects of cisapride on gastrointestinal motor activity and gastric emptying of disopyramide.
Topics: Administration, Oral; Animals; Arrhythmias, Cardiac; Cisapride; Disopyramide; Dogs; Drug Synergism; | 1992 |
The effect of pretreatment with moricizine on early arrhythmia resulting from myocardial ischemia in rats.
Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Hemodynamics; Male; Mexiletine; Moric | 1992 |
Steady-state pharmacokinetics and bioavailability of total and unbound disopyramide in children with cardiac arrhythmias.
Topics: Arrhythmias, Cardiac; Biological Availability; Child; Child, Preschool; Disopyramide; Female; Fluore | 1992 |
[Assessment of anti-arrhythmic activity of palpitin and cardio-hemodynamic effects of its administration].
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Disopyramide; Echocardi | 1990 |
Antiarrhythmic and cardiovascular profiles of the fused indole compound (3aR,12R,12aR,12bS)-12-amino-2,3,3a,4,11,12,12a,12b-octahydro-10-hydrox yisoquino [2,1,8-lma]carbazol-5(1H)-one hydrochloride 1.5 hydrate.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Carbazoles; Chloroform; Disopyramide; Dogs; F | 1991 |
Disopyramide and inducible arrhythmias.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Humans | 1991 |
Combination antiarrhythmic treatment among class Ia, Ib, and II agents for ventricular arrhythmias.
Topics: Administration, Oral; Adult; Aged; Arrhythmias, Cardiac; Disopyramide; Drug Administration Schedule; | 1991 |
[Therapeutic drug monitoring of disopyramide, mexiletine, aprindine and beta blockers].
Topics: Adrenergic beta-Antagonists; Aprindine; Arrhythmias, Cardiac; Biological Availability; Chromatograph | 1990 |
[Effect of amiodarone and disopyramide on the results of electrocardiographic exercise stress testing in patients with coronary disease].
Topics: Amiodarone; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Electrocardiography; Exercise Test | 1990 |
Results of the treatment of cardiac arrhythmias with Palpitin.
Topics: Adult; Aged; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Female; Heart Failure; Humans; Hy | 1990 |
Effects of lidocaine, disopyramide and verapamil on the in vivo triggered ventricular arrhythmia in digitalized canine heart.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Digitalis Glycosides; Disopyramide; Dogs; Dos | 1990 |
Analysis of ventricular arrhythmias in patients with dilated cardiomyopathy--relationship between the effects of antiarrhythmic agents and severity of myocardial lesions.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Disop | 1990 |
Antiarrhythmic drugs. Clinical pharmacology of the old and the new agents.
Topics: Acecainide; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden; Delayed-Action | 1985 |
[Gated blood pool imaging in the diagnosis and management of arrhythmia].
Topics: Arrhythmias, Cardiac; Cardiac Complexes, Premature; Cardiac Output; Disopyramide; Electrocardiograph | 1985 |
Effects of diet-induced hypokalaemia on the antiarrhythmic and electrophysiological actions of prolonged oral treatment with either amiodarone or disopyramide in the anaesthetised rat.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Diet; Disopyramid | 1987 |
[Treatment of ectopic ventricular activity with palpitin (disopyramide)].
Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Disopyramide; Drug Evaluation; Elec | 1987 |
[Comparative study of the effectiveness of ethacizine, etmozin and Ritmilen in patients with ventricular rhythmic disorders].
Topics: Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Disopyramide; Dru | 1987 |
Potentially fatal interaction between erythromycin and disopyramide.
Topics: Aged; Aged, 80 and over; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Disopyramide; Drug Inte | 1989 |
Evaluation of antiarrhythmic drug efficacy using holter electrocardiographic technique.
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Cardiac Complexes, | 1985 |
[A case of non-insulin dependent diabetes mellitus whose insulin requirement was markedly reduced after disopyramide treatment in arrhythmia].
Topics: Aged; Arrhythmias, Cardiac; Blood Glucose; Diabetes Mellitus, Type 2; Disopyramide; Female; Humans; | 1989 |
[Changes in thrombocyte-vascular hemostasis and cyclic nucleotide levels after anti-arrhythmia therapy in patients with ischemic heart disease].
Topics: Adult; Aged; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Female; Humans; Male; Mexiletine; | 1989 |
[Effect of ritmilen and allapinin on prostanoid and cyclic nucleotide levels in patients with cardiac rhythm disorders].
Topics: Aconitine; Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cyclic AMP; Cyclic GMP; Dinoprost; D | 1987 |
Antiarrhythmic drug therapy (Part 1). Benefits and hazards.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compou | 1985 |
Combination of disopyramide and mexiletine for better tolerance and additive effects for treatment of ventricular arrhythmias.
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Disopyramide; Drug Therapy, Combination; Elect | 1989 |
Long-term therapy with disopyramide phosphate: side effects and effectiveness.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Disopyramide; Drug Tolerance; El | 1986 |
The clinical scope of disopyramide. A clinical symposium. San Antonio, Texas, November 5, 1984. Proceedings.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Humans | 1987 |
Long-term use of controlled-release disopyramide in patients with severe ventricular arrhythmias.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Delayed-Action Preparations; Disopyramide | 1987 |
[Clinical effectiveness of palpitin in treating heart rhythm disorders in ischemic heart disease patients].
Topics: Aged; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Drug Evaluation; Electrocardiography; Fe | 1987 |
Antiarrhythmic efficacy of penticainide and comparison with disopyramide, flecainide, propafenone and mexiletine by acute oral drug testing.
Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chronic Disease; Di | 1987 |
Assessment of drug effects on spontaneous and induced ventricular arrhythmias in a 24-h canine infarction model.
Topics: Anilides; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Dogs; Electrocardiogr | 1987 |
[Effect of Ritmilen and allapinin on central hemodynamics and myocardial contractility of patients with heart rhythm disorders].
Topics: Aconitine; Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Depression, Chemical; Disopyramide; | 1987 |
[A combination of kordaron with ritmilen: its effect on the electrophysiology of the heart and its clinical effectiveness].
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Disopyramide; | 1988 |
Effects of procainamide and disopyramide on long chain acyl carnitine and long chain acyl CoA concentrations in the ischemic heart.
Topics: Acyl Coenzyme A; Animals; Arrhythmias, Cardiac; Carnitine; Coronary Disease; Disopyramide; Dogs; Fat | 1988 |
[Clinico-pharmacological interactions of digoxin with ethmozine, disopyramide and amiodarone].
Topics: Amiodarone; Arrhythmias, Cardiac; Coronary Disease; Digoxin; Disopyramide; Drug Synergism; Drug Ther | 1988 |
Therapeutic effectiveness and plasma levels of single or combination use of class I antiarrhythmic agents for ventricular arrhythmias.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Chronic Disease; Disopyramide; | 1988 |
Clinical pharmacokinetics of controlled-release disopyramide in patients with cardiac arrhythmias.
Topics: Adult; Arrhythmias, Cardiac; Delayed-Action Preparations; Disopyramide; Female; Half-Life; Humans; M | 1988 |
Clinical characteristics of patients with ventricular fibrillation during antiarrhythmic drug therapy.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Digitalis Glycosides; Disopyramide; Diuretics; Drug Th | 1988 |
Actions of a newly synthesized compound (711389-S) on various types of experimentally induced arrhythmias in mammalian species in situ.
Topics: Aconitine; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Dogs; Epinephrine; F | 1988 |
Examination of the anti-arrhythmic effect of Palpitin (disopyramide).
Topics: Arrhythmias, Cardiac; Disopyramide; Electrocardiography; Female; Humans; Male; Middle Aged | 1987 |
Antiarrhythmic effects of a novel diamine derivative, AN-132, on several animal models of cardiac arrhythmias.
Topics: Aconitine; Anilides; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chloroform; Disopyramide | 1987 |
[Mexiletine in the treatment of ventricular arrhythmias].
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Child; Disopyramide; Drug Evaluation; Electrocardiogr | 1986 |
[Ritmilen in the treatment of cardiac rhythm disorders].
Topics: Adult; Arrhythmias, Cardiac; Depression, Chemical; Disopyramide; Drug Evaluation; Female; Heart Rate | 1986 |
Combined therapy with disopyramide and amiodarone: a report of 11 cases.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Disopyramide; Drug Therapy, Combination; Female; Huma | 1986 |
Aggravation of ventricular arrhythmia. A drug-induced complication.
Topics: Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Drug Evaluation; El | 1985 |
Measurement of plasma disopyramide as a guide to paediatric use.
Topics: Administration, Oral; Adolescent; Age Factors; Arrhythmias, Cardiac; Child; Child, Preschool; Disopy | 1986 |
N-(2,6-Dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165): a new potent and long-acting antiarrhythmic agent.
Topics: Anesthetics, Local; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cell Membrane; Coronary C | 1985 |
[Treatment of disturbances of cardiac rhythm using intravenous disopyramide].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Brad | 1974 |
Continuous ECG (Holter) recordings in the evaluation of antiarrhythmic drugs.
Topics: Arrhythmias, Cardiac; Cardiac Complexes, Premature; Disopyramide; Drug Evaluation; Electrocardiograp | 1974 |
Synthesis and antiarrhythmic activity of 5,5-disubstituted-3-aminoalkylhydantions and some heterocyclic and noncyclic analogues.
Topics: Alkylation; Amides; Animals; Arrhythmias, Cardiac; Diethylamines; Dimethylamines; Disopyramide; Hete | 1974 |
[Electrophysiological principles of the action of antiarrhythmia agents].
Topics: Ajmaline; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Electrophysiology; Heart; Huma | 1974 |
[Therapeutic value of Rhytmodan in the management of ectopic arrhythmias].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Electrocardiography; Evalua | 1972 |
[Disopyramide in heart arrhythmias].
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Evaluation Stud | 1972 |
Electrophysiological evaluation of disopyramide in man.
Topics: Adult; Aged; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Catheterization; Disopyr | 1973 |
[Clinical evaluation of Rhytmodan in heart rhythm disorders].
Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Drug | 1973 |
[Prevention and treatment of cardiac arrhythmias with rhythmodan (disopyramide)].
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Electrocardiogr | 1973 |
[Effects of disopyramide on the atrio-ventricular conduction in man. Preliminary results in 13 cases studied by means of recording bundle of His].
Topics: Arrhythmias, Cardiac; Bundle of His; Disopyramide; Heart Conduction System; Humans; Pyridines | 1973 |
[Medical treatment of disturbances of the heart rhythm].
Topics: Ajmaline; Amiodarone; Arrhythmias, Cardiac; Digoxin; Disopyramide; Humans; Procainamide; Propranolol | 1973 |
[Anti-arrhythmic action of disopyramide in comparison with that of quinidine].
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Evaluation Stud | 1971 |